DE10052590A1 - Use of 2-hydrazino-1,3-thiazoles as antioxidants - Google Patents
Use of 2-hydrazino-1,3-thiazoles as antioxidantsInfo
- Publication number
- DE10052590A1 DE10052590A1 DE10052590A DE10052590A DE10052590A1 DE 10052590 A1 DE10052590 A1 DE 10052590A1 DE 10052590 A DE10052590 A DE 10052590A DE 10052590 A DE10052590 A DE 10052590A DE 10052590 A1 DE10052590 A1 DE 10052590A1
- Authority
- DE
- Germany
- Prior art keywords
- groups
- hydrazino
- represent
- carbon atoms
- atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- BTWNEJOURYOHME-UHFFFAOYSA-N 1,3-thiazol-2-ylhydrazine Chemical class NNC1=NC=CS1 BTWNEJOURYOHME-UHFFFAOYSA-N 0.000 title claims abstract description 31
- 239000003963 antioxidant agent Substances 0.000 title claims description 27
- 238000002360 preparation method Methods 0.000 claims abstract description 40
- 239000002537 cosmetic Substances 0.000 claims abstract description 23
- 150000003839 salts Chemical class 0.000 claims abstract description 13
- -1 4-methylphenylmethyl Chemical group 0.000 claims description 67
- 125000004432 carbon atom Chemical group C* 0.000 claims description 45
- 239000002516 radical scavenger Substances 0.000 claims description 21
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 20
- 239000000126 substance Substances 0.000 claims description 18
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 15
- 239000000460 chlorine Substances 0.000 claims description 15
- 229910052801 chlorine Inorganic materials 0.000 claims description 15
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 14
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 14
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 13
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 13
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 13
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 13
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 13
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 12
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 12
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 12
- 125000004076 pyridyl group Chemical group 0.000 claims description 12
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 12
- 229910052757 nitrogen Inorganic materials 0.000 claims description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 125000003342 alkenyl group Chemical group 0.000 claims description 8
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 125000001153 fluoro group Chemical group F* 0.000 claims description 8
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052794 bromium Inorganic materials 0.000 claims description 7
- 125000000623 heterocyclic group Chemical group 0.000 claims description 7
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 6
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 6
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 6
- 229910052731 fluorine Inorganic materials 0.000 claims description 6
- 239000011737 fluorine Substances 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 150000002825 nitriles Chemical class 0.000 claims description 6
- 235000016709 nutrition Nutrition 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 6
- 125000003107 substituted aryl group Chemical group 0.000 claims description 6
- 229910052717 sulfur Chemical group 0.000 claims description 6
- 239000011593 sulfur Chemical group 0.000 claims description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
- 125000005842 heteroatom Chemical group 0.000 claims description 5
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- 229940124530 sulfonamide Drugs 0.000 claims description 5
- 150000003456 sulfonamides Chemical class 0.000 claims description 5
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- RFKPNKBREOEDQW-UHFFFAOYSA-N (6-tert-butyl-1,3-benzothiazol-2-yl)hydrazine Chemical compound CC(C)(C)C1=CC=C2N=C(NN)SC2=C1 RFKPNKBREOEDQW-UHFFFAOYSA-N 0.000 claims description 2
- JYSUYJCLUODSLN-UHFFFAOYSA-N 1,3-benzothiazol-2-ylhydrazine Chemical compound C1=CC=C2SC(NN)=NC2=C1 JYSUYJCLUODSLN-UHFFFAOYSA-N 0.000 claims description 2
- VTOUNUQLXMNNMQ-UHFFFAOYSA-N (4-phenyl-2-thiazolyl)hydrazine Chemical compound S1C(NN)=NC(C=2C=CC=CC=2)=C1 VTOUNUQLXMNNMQ-UHFFFAOYSA-N 0.000 claims 1
- QAMZBKMFWQSHDV-UHFFFAOYSA-N (6-methoxy-1,3-benzothiazol-2-yl)hydrazine Chemical compound COC1=CC=C2N=C(NN)SC2=C1 QAMZBKMFWQSHDV-UHFFFAOYSA-N 0.000 claims 1
- QITJGSMHKVXOFR-UHFFFAOYSA-N 1,3-benzoxazol-2-ylhydrazine Chemical compound C1=CC=C2OC(NN)=NC2=C1 QITJGSMHKVXOFR-UHFFFAOYSA-N 0.000 claims 1
- PXUYWNZBZXDJEU-UHFFFAOYSA-N 1h-benzimidazol-2-ylhydrazine Chemical compound C1=CC=C2NC(NN)=NC2=C1 PXUYWNZBZXDJEU-UHFFFAOYSA-N 0.000 claims 1
- JFQMRPIXIZBMQO-UHFFFAOYSA-N 2-hydrazinyl-1,3-benzothiazole-6-sulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=C2SC(NN)=NC2=C1 JFQMRPIXIZBMQO-UHFFFAOYSA-N 0.000 claims 1
- PJVVBMWIMGMGGP-UHFFFAOYSA-N [(4-methyl-1,3-thiazol-2-yl)amino]azanium;chloride Chemical compound Cl.CC1=CSC(NN)=N1 PJVVBMWIMGMGGP-UHFFFAOYSA-N 0.000 claims 1
- SBTQTLQQHWLTHH-UHFFFAOYSA-N [1,3]thiazolo[5,4-b]pyridin-2-ylhydrazine Chemical compound C1=CN=C2SC(NN)=NC2=C1 SBTQTLQQHWLTHH-UHFFFAOYSA-N 0.000 claims 1
- XSKSLQRTKKZBIH-UHFFFAOYSA-N [5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]hydrazine Chemical compound S1C(NN)=NN=C1C1=CC=C(F)C=C1 XSKSLQRTKKZBIH-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 abstract description 6
- 230000009931 harmful effect Effects 0.000 abstract description 5
- 241000124008 Mammalia Species 0.000 abstract description 4
- 239000003642 reactive oxygen metabolite Substances 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 description 21
- 235000006708 antioxidants Nutrition 0.000 description 20
- 239000003921 oil Substances 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 16
- 150000003254 radicals Chemical class 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 7
- 150000001298 alcohols Chemical class 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 125000004122 cyclic group Chemical group 0.000 description 5
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- DTOSIQBPPRVQHS-PDBXOOCHSA-N (Z,Z,Z)-Octadeca-9,12,15-trienoic acid Natural products CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000000475 sunscreen effect Effects 0.000 description 4
- 239000000516 sunscreening agent Substances 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 235000014692 zinc oxide Nutrition 0.000 description 4
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 206010040829 Skin discolouration Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 229940087168 alpha tocopherol Drugs 0.000 description 3
- 238000006701 autoxidation reaction Methods 0.000 description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 238000007539 photo-oxidation reaction Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 239000003549 soybean oil Substances 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- 229940031439 squalene Drugs 0.000 description 3
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 230000037072 sun protection Effects 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 125000002640 tocopherol group Chemical class 0.000 description 3
- 235000019149 tocopherols Nutrition 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- 235000004835 α-tocopherol Nutrition 0.000 description 3
- 239000002076 α-tocopherol Substances 0.000 description 3
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- OFJBYLCQNJHFMI-UHFFFAOYSA-N 2,5-dihydro-1,2-oxazole Chemical compound C1ONC=C1 OFJBYLCQNJHFMI-UHFFFAOYSA-N 0.000 description 2
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 2
- 125000006020 2-methyl-1-propenyl group Chemical group 0.000 description 2
- 125000006022 2-methyl-2-propenyl group Chemical group 0.000 description 2
- CFFZDZCDUFSOFZ-UHFFFAOYSA-N 3,4-Dihydroxy-phenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C(O)=C1 CFFZDZCDUFSOFZ-UHFFFAOYSA-N 0.000 description 2
- DZAUWHJDUNRCTF-UHFFFAOYSA-N 3-(3,4-dihydroxyphenyl)propanoic acid Chemical compound OC(=O)CCC1=CC=C(O)C(O)=C1 DZAUWHJDUNRCTF-UHFFFAOYSA-N 0.000 description 2
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical class [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 239000004904 UV filter Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 150000001448 anilines Chemical class 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 235000021324 borage oil Nutrition 0.000 description 2
- 239000010474 borage seed oil Substances 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000008139 complexing agent Substances 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 229960002433 cysteine Drugs 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000007854 depigmenting agent Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- BOLQJTPHPSDZHR-UHFFFAOYSA-N dihydroferulic acid Chemical compound COC1=CC(CCC(O)=O)=CC=C1O BOLQJTPHPSDZHR-UHFFFAOYSA-N 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 2
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 2
- 229960002733 gamolenic acid Drugs 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- QRMZSPFSDQBLIX-UHFFFAOYSA-N homovanillic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1O QRMZSPFSDQBLIX-UHFFFAOYSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- RAPXDXJBAYUBHI-UHFFFAOYSA-N n-Dodecansaeure-n-decylester Natural products CCCCCCCCCCCC(=O)OCCCCCCCCCC RAPXDXJBAYUBHI-UHFFFAOYSA-N 0.000 description 2
- 230000037125 natural defense Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 150000002927 oxygen compounds Chemical class 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 150000007965 phenolic acids Chemical class 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- PDHSAQOQVUXZGQ-JKSUJKDBSA-N (2r,3s)-2-(3,4-dihydroxyphenyl)-3-methoxy-3,4-dihydro-2h-chromene-5,7-diol Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2OC)=CC=C(O)C(O)=C1 PDHSAQOQVUXZGQ-JKSUJKDBSA-N 0.000 description 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical class CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- CSNIZNHTOVFARY-UHFFFAOYSA-N 1,2-benzothiazole Chemical compound C1=CC=C2C=NSC2=C1 CSNIZNHTOVFARY-UHFFFAOYSA-N 0.000 description 1
- KTZQTRPPVKQPFO-UHFFFAOYSA-N 1,2-benzoxazole Chemical compound C1=CC=C2C=NOC2=C1 KTZQTRPPVKQPFO-UHFFFAOYSA-N 0.000 description 1
- RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical class NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- UPUWMQZUXFAUCJ-UHFFFAOYSA-N 2,5-dihydro-1,2-thiazole Chemical compound C1SNC=C1 UPUWMQZUXFAUCJ-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical group COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- PFPQMWRASYNLMZ-LGIMBNBCSA-N 2-(3,4-dihydroxyphenyl)-3-[(2s,3r,4r,5s,6r)-3,4-dihydroxy-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 PFPQMWRASYNLMZ-LGIMBNBCSA-N 0.000 description 1
- UXGVMFHEKMGWMA-UHFFFAOYSA-N 2-benzofuran Chemical compound C1=CC=CC2=COC=C21 UXGVMFHEKMGWMA-UHFFFAOYSA-N 0.000 description 1
- LYTMVABTDYMBQK-UHFFFAOYSA-N 2-benzothiophene Chemical compound C1=CC=CC2=CSC=C21 LYTMVABTDYMBQK-UHFFFAOYSA-N 0.000 description 1
- ICGLGDINCXDWJB-UHFFFAOYSA-N 2-benzylprop-2-enamide Chemical compound NC(=O)C(=C)CC1=CC=CC=C1 ICGLGDINCXDWJB-UHFFFAOYSA-N 0.000 description 1
- IJVRPNIWWODHHA-UHFFFAOYSA-N 2-cyanoprop-2-enoic acid Chemical class OC(=O)C(=C)C#N IJVRPNIWWODHHA-UHFFFAOYSA-N 0.000 description 1
- 229940106004 2-ethylhexyl benzoate Drugs 0.000 description 1
- LWLRMRFJCCMNML-UHFFFAOYSA-N 2-ethylhexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CC)CCCC LWLRMRFJCCMNML-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- MWKPHOIHTLQZIY-UHFFFAOYSA-N 2-hexyldecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC MWKPHOIHTLQZIY-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- PGJDCIDLMPSNPX-UHFFFAOYSA-N 2-octyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCC PGJDCIDLMPSNPX-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 1
- VHMICKWLTGFITH-UHFFFAOYSA-N 2H-isoindole Chemical compound C1=CC=CC2=CNC=C21 VHMICKWLTGFITH-UHFFFAOYSA-N 0.000 description 1
- YHWMFDLNZGIJSD-UHFFFAOYSA-N 2h-1,4-oxazine Chemical compound C1OC=CN=C1 YHWMFDLNZGIJSD-UHFFFAOYSA-N 0.000 description 1
- ZAISDHPZTZIFQF-UHFFFAOYSA-N 2h-1,4-thiazine Chemical compound C1SC=CN=C1 ZAISDHPZTZIFQF-UHFFFAOYSA-N 0.000 description 1
- RGHMISIYKIHAJW-UHFFFAOYSA-N 3,4-dihydroxymandelic acid Chemical compound OC(=O)C(O)C1=CC=C(O)C(O)=C1 RGHMISIYKIHAJW-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 125000006046 3-methyl-1-pentenyl group Chemical group 0.000 description 1
- 125000006050 3-methyl-2-pentenyl group Chemical group 0.000 description 1
- 125000006054 3-methyl-3-pentenyl group Chemical group 0.000 description 1
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 1
- GTKNRXQSCVVESA-UHFFFAOYSA-N 3h-indazole Chemical compound C1=CC=C2CN=NC2=C1 GTKNRXQSCVVESA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- UFTHEDBYLPFRDP-UHFFFAOYSA-N 5,6-dihydro-2h-oxazine Chemical compound C1CC=CNO1 UFTHEDBYLPFRDP-UHFFFAOYSA-N 0.000 description 1
- MSTFRUQNYRRUKZ-UHFFFAOYSA-N 5,6-dihydro-2h-thiazine Chemical compound C1CC=CNS1 MSTFRUQNYRRUKZ-UHFFFAOYSA-N 0.000 description 1
- WHDIPFLMGHMXGP-UHFFFAOYSA-N 5-(aminomethyl)benzene-1,2,3-triol Chemical compound NCC1=CC(O)=C(O)C(O)=C1 WHDIPFLMGHMXGP-UHFFFAOYSA-N 0.000 description 1
- HQULYFAKUZDRPB-UHFFFAOYSA-N 6-bromo-2-[4-(trifluoromethoxy)phenoxy]-1,3-benzothiazole Chemical compound BrC1=CC2=C(N=C(S2)OC2=CC=C(C=C2)OC(F)(F)F)C=C1 HQULYFAKUZDRPB-UHFFFAOYSA-N 0.000 description 1
- SJIDAAGFCNIAJP-UHFFFAOYSA-N 6-methylheptyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCC(C)C SJIDAAGFCNIAJP-UHFFFAOYSA-N 0.000 description 1
- XUVVLJKRLAXOKZ-UHFFFAOYSA-N 7-methyloctyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCC(C)C XUVVLJKRLAXOKZ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- HKIKAXXIWJHWLY-ZIIYPAMZSA-N Aloesin Chemical compound C=12OC(CC(=O)C)=CC(=O)C2=C(C)C=C(O)C=1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HKIKAXXIWJHWLY-ZIIYPAMZSA-N 0.000 description 1
- HKIKAXXIWJHWLY-QEVGBQTESA-N Aloesin Natural products O=C(CC=1Oc2c([C@H]3[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O3)c(O)cc(C)c2C(=O)C=1)C HKIKAXXIWJHWLY-QEVGBQTESA-N 0.000 description 1
- 108010085443 Anserine Proteins 0.000 description 1
- 244000139693 Arctostaphylos uva ursi Species 0.000 description 1
- 235000012871 Arctostaphylos uva ursi Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- XHVAWZZCDCWGBK-WYRLRVFGSA-M Aurothioglucose Chemical compound OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O XHVAWZZCDCWGBK-WYRLRVFGSA-M 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 239000003508 Dilauryl thiodipropionate Substances 0.000 description 1
- 239000002656 Distearyl thiodipropionate Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 241001002197 Juglans mollis Species 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N Lactic Acid Natural products CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N N-phenyl amine Natural products NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 241000207836 Olea <angiosperm> Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000210053 Potentilla elegans Species 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- CGQCWMIAEPEHNQ-UHFFFAOYSA-N Vanillylmandelic acid Chemical compound COC1=CC(C(O)C(O)=O)=CC=C1O CGQCWMIAEPEHNQ-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- BZUVPTAFNJMPEZ-CLFAGFIQSA-N [(z)-docos-13-enyl] (z)-docos-13-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCOC(=O)CCCCCCCCCCC\C=C/CCCCCCCC BZUVPTAFNJMPEZ-CLFAGFIQSA-N 0.000 description 1
- TXZRBCSUYLEATA-GALHSAGASA-N [(z)-docos-13-enyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC TXZRBCSUYLEATA-GALHSAGASA-N 0.000 description 1
- CTBNYRDNMZZICP-UHFFFAOYSA-N [O-][N+](I)=O Chemical compound [O-][N+](I)=O CTBNYRDNMZZICP-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 206010064930 age-related macular degeneration Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000005227 alkyl sulfonate group Chemical group 0.000 description 1
- 150000008052 alkyl sulfonates Chemical group 0.000 description 1
- 125000004422 alkyl sulphonamide group Chemical group 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000005417 aminobenzoic acid derivatives Chemical class 0.000 description 1
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 1
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 229960001799 aurothioglucose Drugs 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- WURBFLDFSFBTLW-UHFFFAOYSA-N benzil Chemical group C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 WURBFLDFSFBTLW-UHFFFAOYSA-N 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- UADWUILHKRXHMM-ZDUSSCGKSA-N benzoflex 181 Natural products CCCC[C@H](CC)COC(=O)C1=CC=CC=C1 UADWUILHKRXHMM-ZDUSSCGKSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- DRVWBEJJZZTIGJ-UHFFFAOYSA-N cerium(3+);oxygen(2-) Chemical class [O-2].[O-2].[O-2].[Ce+3].[Ce+3] DRVWBEJJZZTIGJ-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 125000001651 cyanato group Chemical group [*]OC#N 0.000 description 1
- 125000006165 cyclic alkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 125000003678 cyclohexadienyl group Chemical group C1(=CC=CCC1)* 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000058 cyclopentadienyl group Chemical group C1(=CC=CC1)* 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 125000005363 dialkylsulfonamide group Chemical group 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 235000019304 dilauryl thiodipropionate Nutrition 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- PWWSSIYVTQUJQQ-UHFFFAOYSA-N distearyl thiodipropionate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCCCCCCCC PWWSSIYVTQUJQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019305 distearyl thiodipropionate Nutrition 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- ZSWFCLXCOIISFI-UHFFFAOYSA-N endo-cyclopentadiene Natural products C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002468 fat body Anatomy 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000004872 foam stabilizing agent Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 229940065115 grapefruit extract Drugs 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001261 isocyanato group Chemical group *N=C=O 0.000 description 1
- 150000002527 isonitriles Chemical class 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- AMWRITDGCCNYAT-UHFFFAOYSA-L manganese oxide Inorganic materials [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 1
- PPNAOCWZXJOHFK-UHFFFAOYSA-N manganese(2+);oxygen(2-) Chemical class [O-2].[Mn+2] PPNAOCWZXJOHFK-UHFFFAOYSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- SOXAGEOHPCXXIO-DVOMOZLQSA-N menthyl anthranilate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-DVOMOZLQSA-N 0.000 description 1
- 229960002248 meradimate Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- VTWKXBJHBHYJBI-UHFFFAOYSA-N n-benzylidenehydroxylamine Chemical class ON=CC1=CC=CC=C1 VTWKXBJHBHYJBI-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical class [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- OBFVUHBJCUHVPI-UHFFFAOYSA-N pentadecyl benzoate Chemical compound CCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1 OBFVUHBJCUHVPI-UHFFFAOYSA-N 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- PZQSQRCNMZGWFT-QXMHVHEDSA-N propan-2-yl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC(C)C PZQSQRCNMZGWFT-QXMHVHEDSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- ZVJHJDDKYZXRJI-UHFFFAOYSA-N pyrroline Natural products C1CC=NC1 ZVJHJDDKYZXRJI-UHFFFAOYSA-N 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 150000003902 salicylic acid esters Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229960002718 selenomethionine Drugs 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Chemical class [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- ARCJQKUWGAZPFX-UHFFFAOYSA-N stilbene oxide Chemical compound O1C(C=2C=CC=CC=2)C1C1=CC=CC=C1 ARCJQKUWGAZPFX-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 150000001629 stilbenes Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 150000003567 thiocyanates Chemical class 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 239000012873 virucide Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical class [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Die Erfindung betrifft die Verwendung von 2-Hydrazino-1,3-thiazolen als Antioxi dantien oder Radikalfänger, bevorzugt als Antioxidantien oder Radikalfänger in kosmetischen, dermatologischen sowie der Ernährung oder dem Genuss dienenden Zubereitungen. Die Erfindung betrifft zudem die Verwendung dieser Zubereitungen zum Schutz von Zellen und Gewebe von Säugern vor den die Alterung beschleu nigenden schädlichen Einflüssen von Radikalen und reaktiven Sauerstoffverbin dungen.The invention relates to the use of 2-hydrazino-1,3-thiazoles as antioxi dantien or radical scavengers, preferably as antioxidants or radical scavengers in cosmetic, dermatological as well as serving nutrition or pleasure Preparations. The invention also relates to the use of these preparations to protect mammalian cells and tissues from accelerating aging harmful effects of radicals and reactive oxygen compounds fertilize.
Eine Reihe von Krankheiten und Altersschäden von Organismen, insbesondere von Säugern, wird durch reaktive Sauerstoffspezies und andere reaktive Radikale aus gelöst oder verstärkt. So werden z. B. spezielle Aspekte der Photoalterung der Haut, die Schädigung der Retina bei der altersbedingten Makula-Degeneration, die Trü bung der Linse beim Katarakt, spezielle Arten der Cancerogenese und die Arterio sklerose im ursächlichen Zusammenhang mit der Reaktion biologisch wichtiger Moleküle wie beispielsweise Desoxyribonukleinsäure oder Proteinen mit freien Radikalen gesehen.A number of diseases and age damage to organisms, especially of Mammals are characterized by reactive oxygen species and other reactive radicals solved or reinforced. So z. B. special aspects of photo-aging of the skin, damage to the retina in age-related macular degeneration, the Trü Exercise of the lens in cataracts, special types of cancerogenesis and the arterio sclerosis causally related to the reaction biologically more important Molecules such as deoxyribonucleic acid or proteins with free Seen radicals.
Für kosmetische, dermatologische sowie der Ernährung oder dem Genuss dienende Zubereitungen werden Wirkstoffe gesucht, die in physiologischen Systemen, insbe sondere in Säugetieren, die natürlichen Abwehrmechanismen gegen freie Radikale und reaktive Sauerstoffverbindungen unterstützen oder als Schutzstoffe in Kos metika, Pharmazeutika oder Nahrungsmitteln deren oxidationsempfindlichen Bestandteile vor Autoxidation schützen.For cosmetic, dermatological as well as serving nutrition or pleasure Preparations are searched for active ingredients, in particular in physiological systems especially in mammals, the natural defense mechanisms against free radicals and support reactive oxygen compounds or as protective substances in Kos Metics, pharmaceuticals or foods whose oxidation sensitive Protect components from autoxidation.
Antioxidantien sind Substanzen, die in im Vergleich zu dem oxidierbaren Substrat kleinen Konzentrationen die Oxidation signifikant verzögern oder gänzlich ver hindern. Viele Antioxidantien fungieren gleichzeitig als Radikalfänger und/oder als Komplexbildner für Schwermetallionen. Antioxidants are substances that are in comparison to the oxidizable substrate small concentrations significantly delay the oxidation or completely ver prevent. Many antioxidants act as radical scavengers and / or at the same time Complexing agent for heavy metal ions.
Es wurde gefunden, dass 2-Hydrazino-1,3-thiazole der allgemeinen Formel
It was found that 2-hydrazino-1,3-thiazoles of the general formula
oder deren Salze,
wobei
X ein Stickstoffatom oder ein substituiertes Kohlenstoffatom C-Q2 darstellt,
und
entweder
Q1 und Q2 unabhängig voneinander Wasserstoffatome,
gegebenenfalls Hydroxy- oder Alkyloxy-substituierte unverzweigte, ver
zweigte oder cyclische Alkyl-, Alkenyl-, 1-Oxoalkyl oder 1-Oxoalkenylgrup
pen mit 1 bis 18 Kohlenstoffatomen,
gegebenenfalls substituierte Arylgruppen mit 6 bis 15 Kohlenstoffatomen,
gegebenenfalls substituierte Heterocyclylgruppen mit 2 bis 15 Kohlenstoff
atomen und mindestems einem Heteroatom ausgewählt aus der Gruppe Sau
erstoff, Stickstoff oder Schwefel,
gegebenenfalls substituierte Arylalkyl- oder Aryl-1-oxoalkylgruppen von 7
bis 16 Kohlenstoffatomen,
Halogenatome, Nitrogruppen oder
Gruppen -COOR4, -OR4, -NR4R5, -SO2OR4, -SO2NR4R5 oder
-PO(OR4)(OR5) darstellen,
oder
Q1 und Q2 zusammen einen Rest der allgemeinen Formel (II)
or their salts,
in which
X represents a nitrogen atom or a substituted carbon atom CQ 2 ,
and
either
Q 1 and Q 2 independently of one another are hydrogen atoms,
optionally hydroxyl- or alkyloxy-substituted unbranched, ver branched or cyclic alkyl, alkenyl, 1-oxoalkyl or 1-oxoalkenyl groups with 1 to 18 carbon atoms,
optionally substituted aryl groups with 6 to 15 carbon atoms,
optionally substituted heterocyclyl groups with 2 to 15 carbon atoms and at least one heteroatom selected from the group consisting of oxygen, nitrogen or sulfur,
optionally substituted arylalkyl or aryl-1-oxoalkyl groups of 7 to 16 carbon atoms,
Halogen atoms, nitro groups or
Represent groups -COOR 4 , -OR 4 , -NR 4 R 5 , -SO 2 OR 4 , -SO 2 NR 4 R 5 or -PO (OR 4 ) (OR 5 ),
or
Q 1 and Q 2 together represent a radical of the general formula (II)
darstellen,
wobei
X1, X2 und X3 unabhängig voneinander entweder Stickstoffatome oder Kohlenstoff
atome mit den Resten R1, R2 bzw. R3 darstellen,
und
R1, R2 und R3 unabhängig voneinander Wasserstoffatome,
gegebenenfalls Hydroxy- oder Alkyloxy-substituierte unverzweigte, ver
zweigte oder cyclische Alkyl-, Alkenyl-, 1-Oxoalkyl oder 1-Oxoalkenylgrup
pen mit 1 bis 18 Kohlenstoffatomen,
gegebenenfalls substituierte Arylgruppen mit 6 bis 15 Kohlenstoffatomen,
gegebenenfalls substituierte Heterocyclylgruppen mit 2 bis 15 Kohlenstoff
atomen und mindestems einem Heteroatom ausgewählt aus der Gruppe Sau
erstoff, Stickstoff oder Schwefel,
gegebenenfalls substituierte Arylalkyl- oder Aryl-1-oxoalkylgruppen von 7
bis 16 Kohlenstoffatomen,
Halogenatome, Nitrogruppen oder
Gruppen -COOR4, -OR4, -NR4R5, -SO2OR4, -SO2NR4R5 oder
-PO(OR4)(OR5) darstellen
und
R4 und R5 unabhängig voneinander Wasserstoffatome, gegebenenfalls Hydroxy- oder
Alkyloxy-substituierte unverzweigte, verzweigte oder cyclische Alkyl-, Alke
nyl-, 1-Oxoalkyl oder 1-Oxoalkenylgruppen mit 1 bis 18 Kohlenstoffatomen,
gegebenenfalls substituierte Arylgruppen mit 6 bis 15 Kohlenstoffatomen,
gegebenenfalls substituierte Arylalkyl- oder Aryl-1-oxoalkylgruppen von 7
bis 16 Kohlenstoffatomen,
darstellen,
als Antioxidantien oder Radikalfänger verwendet werden können.represent
in which
X 1 , X 2 and X 3 independently of one another represent either nitrogen atoms or carbon atoms with the radicals R 1 , R 2 or R 3 ,
and
R 1 , R 2 and R 3 independently of one another are hydrogen atoms,
optionally hydroxyl- or alkyloxy-substituted unbranched, ver branched or cyclic alkyl, alkenyl, 1-oxoalkyl or 1-oxoalkenyl groups with 1 to 18 carbon atoms,
optionally substituted aryl groups with 6 to 15 carbon atoms,
optionally substituted heterocyclyl groups with 2 to 15 carbon atoms and at least one heteroatom selected from the group consisting of oxygen, nitrogen or sulfur,
optionally substituted arylalkyl or aryl-1-oxoalkyl groups of 7 to 16 carbon atoms,
Halogen atoms, nitro groups or
Represent groups -COOR 4 , -OR 4 , -NR 4 R 5 , -SO 2 OR 4 , -SO 2 NR 4 R 5 or -PO (OR 4 ) (OR 5 )
and
R 4 and R 5 independently of one another are hydrogen atoms, optionally hydroxyl- or alkyloxy-substituted unbranched, branched or cyclic alkyl, alkenyl, 1-oxoalkyl or 1-oxoalkenyl groups with 1 to 18 carbon atoms, optionally substituted aryl groups with 6 to 15 carbon atoms, optionally substituted arylalkyl or aryl-1-oxoalkyl groups of 7 to 16 carbon atoms,
represent
can be used as antioxidants or radical scavengers.
Die erfindungsgemäßen 2-Hydrazino-1,3-heteroazole können auch in Form ihrer Tautomeren vorliegen.The 2-hydrazino-1,3-heteroazoles according to the invention can also be in the form of their Tautomers are present.
Eine unverzweigte, verzweigte oder cyclische Alkylgruppe kann 1 bis 18, bevorzugt 1 bis 8, insbesondere bevorzugt 1 bis 6 Kohlenstoffatome enthalten. Beispielsweise seien genannt: Methyl, Ethyl, 1-Propyl, 2-Propyl-, 1-Butyl, 2-Butyl, tert.-Butyl, 2- Methyl, 2-Methylprop-1-yl, Cyclopropyl, Cyclopropylmethyl, 2,2-Dimethylcyclo propyl, Cyclobutyl, Cyclopentyl, Cyclohexyl und verschiedene Stellungsisomere von Methylpentyl.An unbranched, branched or cyclic alkyl group can be 1 to 18, preferred Contain 1 to 8, particularly preferably 1 to 6 carbon atoms. For example may be mentioned: methyl, ethyl, 1-propyl, 2-propyl, 1-butyl, 2-butyl, tert-butyl, 2- Methyl, 2-methylprop-1-yl, cyclopropyl, cyclopropylmethyl, 2,2-dimethylcyclo propyl, cyclobutyl, cyclopentyl, cyclohexyl and various positional isomers of Methylpentyl.
Eine unverzweigte, verzweigte oder cyclische Alkenylgruppe kann 2 bis 18, bevor zugt 2 bis 8, insbesondere bevorzugt 2 bis 6 Kohlenstoffatome enthalten. Beispiels weise seien genannt: Ethenyl, 1- oder 2-Propenyl, 1-, 2- oder 3-Butenyl, 2-Methyl-1- propenyl, 2-Methyl-2-propenyl, 1,3-Butadienyl, 1,3-Pentadienyl, 1,4-Pentenyl, 2,4- Pentenyl, die jeweiligen verschiedenden geradkettigen, cyclischen oder verzweigten Isomere des Pentenyl-, Hexenylrests. Insbesondere bevorzugt sind Ethenyl, 1- oder 2-Propenyl, 1-, 2- oder 3-Butenyl, 2-Methyl-1-propenyl, 2-Methyl-2-propenyl, 3- Methyl-1-pentenyl, 3-Methyl-2-pentenyl, 3-Methyl-3-pentenyl, Cyclopentenyl, Cyclopentadienyl, Cyclohexadienyl und Cyclohexenyl. A straight, branched or cyclic alkenyl group can be 2 to 18 before contains 2 to 8, particularly preferably 2 to 6, carbon atoms. example Wise may be mentioned: ethenyl, 1- or 2-propenyl, 1-, 2- or 3-butenyl, 2-methyl-1- propenyl, 2-methyl-2-propenyl, 1,3-butadienyl, 1,3-pentadienyl, 1,4-pentenyl, 2,4- Pentenyl, the various different straight-chain, cyclic or branched Isomers of the pentenyl, hexenyl radical. Ethenyl, 1- or are particularly preferred 2-propenyl, 1-, 2- or 3-butenyl, 2-methyl-1-propenyl, 2-methyl-2-propenyl, 3- Methyl-1-pentenyl, 3-methyl-2-pentenyl, 3-methyl-3-pentenyl, cyclopentenyl, Cyclopentadienyl, cyclohexadienyl and cyclohexenyl.
Eine unverzweigte, verzweigte oder cyclische 1-Oxo-alkylgruppe kann 1 bis 18, be vorzugt 1 bis 8, insbesondere bevorzugt 1 bis 5 Kohlenstoffatome enthalten. Bei spielsweise seien genannt: Formyl, Acetyl, Propionyl, 2-Methylpropionyl, Butanoyl, 2-Methylbutanoyl, 3-Methylbutanoyl, 2,2-Dimethylpropionyl, Cyclopropylcarboxyl.An unbranched, branched or cyclic 1-oxo-alkyl group can be 1 to 18, preferably contain 1 to 8, particularly preferably 1 to 5 carbon atoms. at Examples include: formyl, acetyl, propionyl, 2-methylpropionyl, butanoyl, 2-methylbutanoyl, 3-methylbutanoyl, 2,2-dimethylpropionyl, cyclopropylcarboxyl.
Eine unverzweigte, verzweigte oder cyclische 1-Oxo-alkenylgruppe kann 3 bis 18, bevorzugt 3 bis 8, insbesondere bevorzugt 3 bis 5 Kohlenstoffatome enthalten. Bei spielsweise seien genannt: Prop-2-enoyl, 2-Methylprop-2-enoyl, 2-Ethyl-prop-2- enoyl, E- oder Z-2-Butenoyl, 3-Butenoyl, E- oder Z-2-Methylbut-2-enoyl, E- oder Z-3-Methylbut-2-enoyl, Z-oder E- 2-Pentenoyl, Z-oder E- 3-Pentenoyl.An unbranched, branched or cyclic 1-oxo-alkenyl group can contain 3 to 18, preferably contain 3 to 8, particularly preferably 3 to 5 carbon atoms. at Examples include: prop-2-enoyl, 2-methylprop-2-enoyl, 2-ethyl-prop-2- enoyl, E- or Z-2-butenoyl, 3-butenoyl, E- or Z-2-methylbut-2-enoyl, E- or Z-3-methylbut-2-enoyl, Z- or E- 2-pentenoyl, Z- or E- 3-pentenoyl.
Arylgruppen mit 6 bis 15 Kohlenstoffatomen, bevorzugt 6 bis 10 Kohlenstoffatomen können beispielsweise sein: Phenyl und Naphtyl.Aryl groups with 6 to 15 carbon atoms, preferably 6 to 10 carbon atoms can be, for example: phenyl and naphthyl.
Eine Heterocyclylgruppe mit 2 bis 15 Kohlentstoffatomen und mindestens einem Atom aus der Gruppe Sauerstoff, Schwefel oder Stickstoff im Ring besteht im allge meinen aus 1 bis 3, bevorzugt 1 oder 2 fünf oder sechsgliedrigen Ringen. Die Heterocyclylgruppe enthält bevorzugt 1 bis 4, insbesondere bevorzugt 1 oder 2 Heteroatome. Bevorzugt sind Furan, Pyrrol, Thiophen, Indol, Isoindol, Benzofuran, Isobenzofuran, Benzothiophen, Isobenzothiophen, Pyrazol, Imidazol, 1,3- oder 1,2- Oxazol, 1,3- oder 1,2-Thiazol, 1,3- oder 1,2-Benzimidazol, 1,3- oder 1,2-Benzoxazol, 1,3- oder 1,2-Benzothiazol, Pyridin, Pyrimidin, Pyrazin, 1,2-, 1,3- oder 1,4-Oxazin, 1,2-, 1,3- oder 1,4-Thiazin, Chinolin, Isochinolin, Benzo-1,2-, -1,3- oder -1,4-diazin oder deren partiell oder vollständig gesättigten Derivate, z. B. Tetrahydrofuran, 1,3- Dioxolan, Pyrrolidin, Pyrrolin, 1,3- oder 1,4-Dioxan, Piperidin, Tetrahydro-2H-py ran, Piperazin, Oxiran oder Aziridin. Insbesondere bevorzugt sind Furan, Pyrrol, In dol, Imidazol, 1,3-Thiazol, 1,3-Benzothiazol, Pyridin, Pyrimidin, Chinolin, Isochinolin oder deren partiell oder vollständig gesättigten Derivate, z. B. Tetrahydro furan, 1,3-Dioxolan, Pyrrolidin, 1,3- oder 1,4-Dioxan, Piperidin oder Tetrahydro-2H- pyran. A heterocyclyl group with 2 to 15 carbon atoms and at least one An atom from the group consisting of oxygen, sulfur or nitrogen in the ring generally exists mean from 1 to 3, preferably 1 or 2 five or six-membered rings. The Heterocyclyl group preferably contains 1 to 4, particularly preferably 1 or 2 Hetero atoms. Furan, pyrrole, thiophene, indole, isoindole, benzofuran, Isobenzofuran, benzothiophene, isobenzothiophene, pyrazole, imidazole, 1,3- or 1,2- Oxazole, 1,3- or 1,2-thiazole, 1,3- or 1,2-benzimidazole, 1,3- or 1,2-benzoxazole, 1,3- or 1,2-benzothiazole, pyridine, pyrimidine, pyrazine, 1,2-, 1,3- or 1,4-oxazine, 1,2-, 1,3- or 1,4-thiazine, quinoline, isoquinoline, benzo-1,2-, -1,3- or -1,4-diazine or their partially or fully saturated derivatives, e.g. B. tetrahydrofuran, 1,3- Dioxolane, pyrrolidine, pyrroline, 1,3- or 1,4-dioxane, piperidine, tetrahydro-2H-py ran, piperazine, oxirane or aziridine. Furan, pyrrole, In are particularly preferred dol, imidazole, 1,3-thiazole, 1,3-benzothiazole, pyridine, pyrimidine, quinoline, Isoquinoline or its partially or fully saturated derivatives, e.g. B. Tetrahydro furan, 1,3-dioxolane, pyrrolidine, 1,3- or 1,4-dioxane, piperidine or tetrahydro-2H- pyran.
Eine Arylalkylgruppe kann aus 6 bis 1 S Kohlenstoffatomen, bevorzugt aus 7 bis 8 Kohlenstoffatomen bestehen und kann beispielsweise sein: Benzyl, 2- oder 1-Phenyl ethyl.An arylalkyl group can consist of 6 to 1 S carbon atoms, preferably 7 to 8 Carbon atoms exist and can be, for example: benzyl, 2- or 1-phenyl ethyl.
Eine Aryl-1-oxo-alkylgruppe kann aus 6 bis 15 Kohlenstoffatomen, bevorzugt aus 7 bis 8 Kohlenstoffatomen bestehen und kann beispielsweise sein: Benzoyl, Phenyl acetyl.An aryl-1-oxo-alkyl group can have 6 to 15 carbon atoms, preferably 7 up to 8 carbon atoms and can be, for example: benzoyl, phenyl acetyl.
Substituenten der Aryl-, Arylalkyl-, Aryl-1-oxoalkyl- und Heterocyclylgruppen kön nen beispielsweise sein: Wasserstoffatome, Alkyl-, Hydroxy-, Alkyloxy-, Thio-, Al kylthio-, Amino-, Alkylamino-, Dialkylamino-, Nitro-, Iod-, Brom-, Fluor-, Chlor-, Azido-, Thiocyanato-, Isothiocyanato-, Cyanato-, Isocyanato-, Nitril-, Isonitril-, Phosphat-, Alkylphosphat-, Dialkylphosphat-, Sulfonsäure-, Alkylsulfonat-, Sulfon amid-, Dialkylsulfonamid- oder Alkylsulfonamidreste. Insbesondere bevorzugt sind Wasserstoffatome, Alkyl-, Hydroxy-, Alkyloxy-, Amino-, Dialkylamino-, Brom-, Fluor-, Chlor-, Nitril-, Sulfonsäure-, Sulfonamid- oder Alkylsulfonatreste.Substituents of the aryl, arylalkyl, aryl-1-oxoalkyl and heterocyclyl groups can Examples include: hydrogen atoms, alkyl, hydroxy, alkyloxy, thio, Al kylthio, amino, alkylamino, dialkylamino, nitro, iodine, bromine, fluorine, chlorine, Azido, thiocyanato, isothiocyanato, cyanato, isocyanato, nitrile, isonitrile, Phosphate, alkyl phosphate, dialkyl phosphate, sulfonic acid, alkyl sulfonate, sulfone amide, dialkylsulfonamide or alkylsulfonamide residues. Are particularly preferred Hydrogen atoms, alkyl, hydroxy, alkyloxy, amino, dialkylamino, bromine, Fluorine, chlorine, nitrile, sulfonic acid, sulfonamide or alkyl sulfonate residues.
Bevorzugt ist die Verwendung der 2-Hydrazino-1,3-thiazole der allgemeinen
Formel (I)
Preference is given to using the 2-hydrazino-1,3-thiazoles of the general formula (I)
oder deren Salze,
wobei
X ein Stickstoffatom oder ein mit Q2 substituiertes Kohlenstoffatom C-Q2
darstellt,
und
entweder
Q1 und Q2 unabhängig voneinander Wasserstoffatome, Methyl-, Trifluormethyl-,
Ethyl-, tert.-Butyl-, Allyl-, 3-Methylbut-2-en-1-yl- oder Acetylgruppen,
Chlor- oder Fluoratome, Nitrogruppen, Gruppen -COOR4, -OR4, -NR4R5,
-SO2OR4, -SO2NR4R5, -PO(OR4)(OR5), oder am Aromaten gegebenenfalls
mit Alkyl-, Hydroxy-, Alkyloxy-, Amino-, Dialkylamino-, Brom-, Fluor-,
Chlor-, Nitril-, Sulfonsäure-, Sulfonamid- oder Alkylsulfonatresten substi
tuierte Phenyl-, Pyridyl-, Pyrazinylgruppen, Phenylmethyl- oder Benzoyl
gruppen darstellen,
oder
Q1 und Q2 zusammen einen Rest der allgemeinen Formel (II)
or their salts,
in which
X represents a nitrogen atom or a carbon atom CQ 2 substituted by Q 2 ,
and
either
Q 1 and Q 2 independently of one another are hydrogen atoms, methyl, trifluoromethyl, ethyl, tert-butyl, allyl, 3-methylbut-2-en-1-yl or acetyl groups, chlorine or fluorine atoms, nitro groups, groups -COOR 4 , -OR 4 , -NR 4 R 5 , -SO 2 OR 4 , -SO 2 NR 4 R 5 , -PO (OR 4 ) (OR 5 ), or on the aromatic optionally with alkyl, hydroxy, Alkyloxy, amino, dialkylamino, bromine, fluorine, chlorine, nitrile, sulfonic acid, sulfonamide or alkylsulfonate radicals represent substituted phenyl, pyridyl, pyrazinyl, phenylmethyl or benzoyl groups,
or
Q 1 and Q 2 together represent a radical of the general formula (II)
darstellen,
wobei
X1, X2 und X3 Kohlenstoffatome mit den Resten R, R2 bzw. R3 darstellen,
und
R1, R2 und R3 unabhängig voneinander Wasserstoffatome, Methyl-, Trifluormethyl-,
Ethyl-, tert.-Butyl-, Allyl-, 3-Methylbut-2-en-1-yl- oder Acetylgruppen,
Phenyl-, Pyridyl-, Pyrazinylgruppen, Phenylmethyl-, 4-Methylphenylmethyl-,
4-Methoxyphenylmethyl- oder Benzoylgruppen, Chlor- oder Fluoratome,
Nitrogruppen, Gruppen -COOR4, -OR4, -NR4R5, -SO2OR4, -SO2NR4R5 oder
-PO(OR4)(OR5) darstellen
und
R4 und R5 unabhängig voneinander Wasserstoffatome, Methyl-, Trifluormethyl-,
Ethyl-, tert.-Butyl-, Allyl-, 3-Methylbut-2-en-1-yl-, Acetyl-, Propionyl oder
Pivaloylgruppen, Phenyl-, Pyridyl-, Pyrazinylgruppen, Phenylmethyl-, 4-
Methylphenylmethyl-, 4-Methoxyphenylmethyl- oder Benzoylgruppen dar
stellen
als Antioxidantien oder Radikalfänger.represent
in which
X 1 , X 2 and X 3 represent carbon atoms with the radicals R, R 2 and R 3 ,
and
R 1 , R 2 and R 3 independently of one another are hydrogen atoms, methyl, trifluoromethyl, ethyl, tert-butyl, allyl, 3-methylbut-2-en-1-yl or acetyl groups, phenyl, pyridyl , Pyrazinyl groups, phenylmethyl, 4-methylphenylmethyl, 4-methoxyphenylmethyl or benzoyl groups, chlorine or fluorine atoms, nitro groups, groups -COOR 4 , -OR 4 , -NR 4 R 5 , -SO 2 OR 4 , -SO 2 NR 4 R 5 or -PO (OR 4 ) (OR 5 )
and
R 4 and R 5 independently of one another are hydrogen atoms, methyl, trifluoromethyl, ethyl, tert-butyl, allyl, 3-methylbut-2-en-1-yl, acetyl, propionyl or pivaloyl groups, phenyl, Pyridyl, pyrazinyl, phenylmethyl, 4-methylphenylmethyl, 4-methoxyphenylmethyl or benzoyl groups
as antioxidants or radical scavengers.
Insbesondere bevorzugt ist die Verwendung von
2-Hydrazino-1,3-benzothiazol
5,6-Dimethoxy-2-hydrazino-1,3-benzothiazol
6-Methoxy-2-hydrazino-1,3-benzothiazol
2-Hydrazino-1,3-benzothiazol-5-sulfonsäure
2-Hydrazino-1,3-benzothiazol-6-sulfonsäure
6-tert.-Butyl-2-hydrazino-1,3-benzothiazol
6-Methyl-2-hydrazino-1,3-benzothiazol
2-Hydrazino-thiazolo-[5,4-b]pyridin
2-Hydrazino-1,3-benzoxazol
2-Hydrazino-1H-benzimidazol
2-Hydrazino-5-(4-fluorphenyl)-1,3,4-thiadiazol
2-Hydrazino-4-phenyl-1,3-thiazol
2-Hydrazino-4-methyl-1,3-thiazol-hydrochlorid
als Antioxidantien oder Radikalfänger.
The use of is particularly preferred
2-hydrazino-1,3-benzothiazole
5,6-dimethoxy-2-hydrazino-1,3-benzothiazole
6-Methoxy-2-hydrazino-1,3-benzothiazole
2-hydrazino-1,3-benzothiazole-5-sulfonic acid
2-hydrazino-1,3-benzothiazole-6-sulfonic acid
6-tert-butyl-2-hydrazino-1,3-benzothiazole
6-methyl-2-hydrazino-1,3-benzothiazole
2-hydrazino-thiazolo [5,4-b] pyridine
2-hydrazino-1,3-benzoxazol
2-hydrazino-1H-benzimidazole
2-hydrazino-5- (4-fluorophenyl) -1,3,4-thiadiazole
2-hydrazino-4-phenyl-1,3-thiazole
2-hydrazino-4-methyl-1,3-thiazole hydrochloride
as antioxidants or radical scavengers.
Überraschenderweise wurde nun gefunden, dass die erfindungsgemäßen 2-Hydra zino-1,3-thiazole sehr gute Radikalfänger und starke Antioxidantien sind. Bevorzugt sind sie als Radikalfänger geeignet. Insbesondere sind die erfindungsgemäßen 2- Hydrazino-1,3-thiazole in der Lage, die schädlichen Einflüsse freier Radikale und/oder oxidativer Prozesse, die beispielsweise durch durch UV-Licht induziert werden, auf und/oder in der menschlichen Haut zu unterdrücken und die natürlichen antioxidativen Prozesse zu unterstützen. Daher können sie als Wirkstoffe in kosme tischen oder dermatologischen Hautaufhellungsmitteln verwendet werden. Die erfindungsgemäßen 2-Hydrazino-1,3-thiazole stellen außerdem sehr gute Antoxi dantien für hochungesättigte Lipide wie beispielsweise Squalen, Lycopin, Carotine, Docosahexaensäure, Eicosapentaensäure, α- oder γ-Linolensäure oder Linolsäure sowie für fette Öle, enthaltend (mehrfach) ungesättigte Fettsäuren, wie beispielsweise Sojaöl, Leinöl, Distelöl, Borretschsamenöl, Nachtkerzenöl, Fischöl, Olivenöl oder Sonnenblumenöl dar. Daher können sie in der Ernährung oder dem Genuss dienen den Zubereitungen, die solche Lipide enthalten, als Antioxidantien verwendet werden. Insbesondere sind die erfindungsgemäßen 2-Hydrazino-1,3-thiazole auch zur Stabilisiserung der reinen Lipide oder fetten Öle oder Gemische derselben hervor ragend geeignet.Surprisingly, it has now been found that the 2-hydra according to the invention zino-1,3-thiazoles are very good radical scavengers and strong antioxidants. Prefers they are suitable as radical scavengers. In particular, the 2- Hydrazino-1,3-thiazoles are able to counter the harmful effects of free radicals and / or oxidative processes, for example induced by UV light be suppressed on and / or in human skin and the natural to support antioxidant processes. Therefore, they can be used as active ingredients in kosme tables or dermatological skin lightening agents can be used. The 2-hydrazino-1,3-thiazoles according to the invention are also very good Antoxi dantien for highly unsaturated lipids such as squalene, lycopene, carotenes, Docosahexaenoic acid, eicosapentaenoic acid, α- or γ-linolenic acid or linoleic acid as well as for fatty oils containing (poly) unsaturated fatty acids, such as Soybean oil, linseed oil, safflower oil, borage seed oil, evening primrose oil, fish oil, or olive oil Sunflower oil. Therefore, they can serve in the diet or enjoyment the preparations containing such lipids are used as antioxidants become. In particular, the 2-hydrazino-1,3-thiazoles according to the invention are also suitable for Stabilization of the pure lipids or fatty oils or mixtures thereof outstandingly suitable.
Die erfindungsgemäßen 2-Hydrazino-1,3-thiazole können bevorzugt in pharma zeutischen, kosmetischen oder dermatologischen Präparaten, bevorzugt zum Schutz von Zellen und Geweben von Säugern, insbesondere der Haut des Menschen, sowie in Nahrungsmitteln gegenüber dem schädlichen Einfluss von freien Radikalen und reaktiven Sauerstoffspezies verwendet werden. Selbstverständlich können die erfin dungsgemäßen 2-Hydrazino-1,3-thiazole und/oder die Zubereitungen, enthaltend die erfindungsgemäßen 2-Hydrazino-1,3-thiazole, auch analog in anderen Einsatzge bieten eingesetzt werden.The 2-hydrazino-1,3-thiazoles according to the invention can preferably in pharma ceutical, cosmetic or dermatological preparations, preferably for protection of cells and tissues of mammals, especially human skin, as well in foods against the harmful effects of free radicals and reactive oxygen species can be used. Of course, the inventions 2-hydrazino-1,3-thiazoles according to the invention and / or the preparations containing the 2-Hydrazino-1,3-thiazoles according to the invention, also analogously in other Einsatzge offer to be used.
Daher betrifft die Verbindungen auch kosmetische, dermatologische sowie der
Ernährung oder dem Genuss dienende Zubereitungen, enthaltend die 2-Hydrazino-
1,3-thiazole der allgemeinen Formel (I)
The compounds therefore also relate to cosmetic, dermatological and nutritional or pleasure-making preparations containing the 2-hydrazino-1,3-thiazoles of the general formula (I)
oder deren Salze,
wobei
X ein Stickstoffatom oder ein substituiertes Kohlenstoffatom C-Q2 darstellt,
und
entweder
Q1 und Q2 unabhängig voneinander Wasserstoffatome, Methyl-, Trifluormethyl-,
Ethyl-, tert.-Butyl-, Allyl-, 3-Methylbut-2-en-1-yl- oder Acetylgruppen,
Chlor- oder Fluoratome, Nitrogruppen, Gruppen -COOR4, -OR4, -NR4R5,
-SO2OR4, -SO2NR4R5, -PO(OR4)(OR5), oder am Aromaten gegebenenfalls
mit Alkyl-, Hydroxy-, Alkyloxy-, Amino-, Dialkylamino-, Brom-, Fluor-,
Chlor-, Nitril-, Sulfonsäure-, Sulfonamid- oder Alkylsulfonatresten
substituierte Phenyl-, Pyridyl-, Pyrazinylgruppen, Phenylmethyl- oder
Benzoylgruppen darstellen,
oder
Q1 und Q2 zusammen einen Rest der allgemeinen Formel (II)
or their salts,
in which
X represents a nitrogen atom or a substituted carbon atom CQ 2 ,
and
either
Q 1 and Q 2 independently of one another are hydrogen atoms, methyl, trifluoromethyl, ethyl, tert-butyl, allyl, 3-methylbut-2-en-1-yl or acetyl groups, chlorine or fluorine atoms, nitro groups, groups -COOR 4 , -OR 4 , -NR 4 R 5 , -SO 2 OR 4 , -SO 2 NR 4 R 5 , -PO (OR 4 ) (OR 5 ), or on the aromatic optionally with alkyl, hydroxy, Alkyloxy, amino, dialkylamino, bromine, fluorine, chlorine, nitrile, sulfonic acid, sulfonamide or alkylsulfonate radicals represent substituted phenyl, pyridyl, pyrazinyl groups, phenylmethyl or benzoyl groups,
or
Q 1 and Q 2 together represent a radical of the general formula (II)
darstellen,
wobei
X1, X2 und X3 Kohlenstoffatome mit den Resten R1, R2 bzw. R3 darstellen,
und
R1, R2 und R3 unabhängig voneinander Wasserstoffatome, Methyl-, Trifluormethyl-,
Ethyl-, tert.-Butyl-, Allyl-, 3-Methylbut-2-en-1-yl- oder Acetylgruppen,
Phenyl-, Pyridyl-, Pyrazinylgruppen, Phenylmethyl-, 4-Methylphenylmethyl-,
4-Methoxyphenylmethyl- oder Benzoylgruppen, Chlor- oder Fluoratome,
Nitrogruppen, Gruppen -COOR4, -OR4, -NR4R5, -SO2OR4, -SO2NR4R5 oder
-PO(OR4)(OR5) darstellen
und
R4 und R5 unabhängig voneinander Wasserstoffatome, Methyl-, Trifluormethyl-,
Ethyl-, tert.-Butyl-, Allyl-, 3-Methylbut-2-en-1-yl-, Acetyl-, Propionyl oder
Pivaloylgruppen, Phenyl-, Pyridyl-, Pyrazinylgruppen, Phenylmethyl-, 4-
Methylphenylmethyl-, 4-Methoxyphenylmethyl- oder Benzoylgruppen dar
stellen.represent
in which
X 1 , X 2 and X 3 represent carbon atoms with the radicals R 1 , R 2 and R 3 ,
and
R 1 , R 2 and R 3 independently of one another are hydrogen atoms, methyl, trifluoromethyl, ethyl, tert-butyl, allyl, 3-methylbut-2-en-1-yl or acetyl groups, phenyl, pyridyl , Pyrazinyl groups, phenylmethyl, 4-methylphenylmethyl, 4-methoxyphenylmethyl or benzoyl groups, chlorine or fluorine atoms, nitro groups, groups -COOR 4 , -OR 4 , -NR 4 R 5 , -SO 2 OR 4 , -SO 2 NR 4 R 5 or -PO (OR 4 ) (OR 5 )
and
R 4 and R 5 independently of one another are hydrogen atoms, methyl, trifluoromethyl, ethyl, tert-butyl, allyl, 3-methylbut-2-en-1-yl, acetyl, propionyl or pivaloyl groups, phenyl, Pyridyl, pyrazinyl, phenylmethyl, 4-methylphenylmethyl, 4-methoxyphenylmethyl or benzoyl groups.
Die erfindungsgemäßen kosmetischen, dermatologischen sowie der Ernährung oder dem Genuss dienenden Zubereitungen unterstützen in physiologischen Systemen die natürlichen Abwehrmechanismen gegen freie Radikale und reaktive Sauerstoffver bindungen und schützen in Kosmetika, Pharmazeutika, Nahrungs- oder Genuss mitteln deren oxidationsempfindlichen Bestandteile vor Autoxidation oder Photooxi dation.The cosmetic, dermatological and nutrition or Preparations for enjoyment support the in physiological systems natural defense mechanisms against free radicals and reactive oxygen bonds and protect in cosmetics, pharmaceuticals, food or beverages means their components sensitive to oxidation before autoxidation or photooxi dation.
Die teilweise bekannten 2-Hydrazino-1,3-thiazole können beispielsweise nach dem in Organic Preparations and Procedures Int. 1974, 6(4), 179-182 beschriebenen Verfahren aus den 2-Amino-1,3-thiazolen hergestellt werden. Letztere können beispielsweise aus den entsprechenden Anilinen oder heterocyclischen Aminen durch Umsetzung mit anorganischen Thiocyanat-Salzen und anschließendem oxidativem Ringschluss des N-Arylthioharnstoffs dargestellt werden (J. Indian Chem. Soc. 1989, 66, 39-41).The partially known 2-hydrazino-1,3-thiazoles can, for example, according to the in Organic Preparations and Procedures Int. 1974, 6 (4), 179-182 Process can be prepared from the 2-amino-1,3-thiazoles. The latter can for example from the corresponding anilines or heterocyclic amines by reaction with inorganic thiocyanate salts and subsequent oxidative ring closure of the N-arylthiourea are shown (J. Indian Chem. Soc. 1989, 66, 39-41).
Die erfindungsgemäßen 2-Hydrazino-1,3-benzothiazole können beispielsweise aus gehend von einem gegebenfalls substituierten Anilin durch Umsetzung mit Kalium, Natrium oder Ammoniumthiocyanat, anschließend durch Chlor, Brom oder Iod ver mitteltem oxidativen Ringschluss und schließlich durch Umsetzung mit Hydrazin oder Hydrazinhydrat dargestellt werden.The 2-hydrazino-1,3-benzothiazoles according to the invention can, for example, from starting from an optionally substituted aniline by reaction with potassium, Sodium or ammonium thiocyanate, then by chlorine, bromine or iodine average oxidative ring closure and finally by reaction with hydrazine or hydrazine hydrate.
Die Herstellung kann anhand des exemplarischen Beispiels 2-Hydrazino-6-tert.-
butyl-1,3-benzothiazols durch das folgende Formelschema erläutert werden:
The preparation can be illustrated using the exemplary example 2-hydrazino-6-tert-butyl-1,3-benzothiazole by the following formula:
Die erfindungsgemäßen Zubereitungen, enthaltend die 2-Hydrazino-1,3-thiazole, werden mit üblichen, an sich bekannten Verfahren hergestellt, dergestalt, dass eins oder mehrere der erfindungsgemäßen 2-Hydrazino-1,3-heteroazole der allgemeinen Formel I oder deren Salze in die Formulierungen eingearbeitet werden, die wie üblich zusammengesetzt sind und zur Behandlung, dem Schutz, der Pflege und der Reinigung der Haut oder der Haare, als Schminkprodukte sowie als Nahrungs- oder Genussmittel dienen können. The preparations according to the invention, containing the 2-hydrazino-1,3-thiazoles, are produced using conventional methods known per se, in such a way that one or more of the 2-hydrazino-1,3-heteroazoles according to the invention of the general Formula I or its salts are incorporated into the formulations which like are commonly composed and for treatment, protection, care and the Cleaning the skin or hair, as make-up products and as food or Luxury goods can serve.
Die erfindungsgemäßen Zubereitungen enthalten 2-Hydrazino-1,3-thiazole in einer wirksamen Menge und gegebenenfalls andere Bestandteile. Sie enthalten 0,0001 Gew.-% bis 30 Gew.-%, bevorzugt 0,001 bis 20 Gew.-%, insbesondere aber 0,001 Gew.-% bis 5 Gew.-%, bezogen auf das Gesamtgewicht der Formulierung, an den erfindungsgemäßen 2-Hydrazino-1,3-thiazolen und können dabei als "Wasser in Öl"-, "Öl in Wasser"-, "Wasser in Öl in Wasser"- oder "Öl in Wasser in Öl"- Emulsionen, als Mikroemulsionen, als Gele, als Lösungen z. B. in Ölen, Alkoholen oder Siliconölen vorliegen. Weitere übliche Hilfs- und Zusatzstoffe können in Mengen von 5 bis 99,9999 Gew.-%, vorzugsweise 10 bis 80 Gew.-%, bezogen auf das Gesamtgewicht der Formulierung, enthalten sein. Ferner können die Formulierungen Wasser in einer Menge bis zu 99,999 Gew.-%, vorzugsweise 5 bis 80 Gew.-%, bezogen auf das Gesamtgewicht der Formulierung, aufweisen.The preparations according to the invention contain 2-hydrazino-1,3-thiazoles in one effective amount and possibly other ingredients. They contain 0.0001% by weight up to 30% by weight, preferably 0.001 to 20% by weight, but in particular 0.001% by weight up to 5% by weight, based on the total weight of the formulation, of the 2-hydrazino-1,3-thiazoles according to the invention and can be "water in Oil "-," Oil in Water "-," Water in Oil in Water "- or" Oil in Water in Oil "- Emulsions, as microemulsions, as gels, as solutions for. B. in oils, alcohols or silicone oils. Other usual auxiliaries and additives can be found in Amounts from 5 to 99.9999% by weight, preferably 10 to 80% by weight, based on the total weight of the formulation. Furthermore, the Formulations water in an amount up to 99.999 wt .-%, preferably 5 to 80% by weight, based on the total weight of the formulation.
Zur Herstellung der erfindungsgemäßen Zubereitungen, können in einer weiteren Ausführungsform die 2-Hydrazino-1,3-thiazole der allgemeinen Formel I auch vorher in Liposomen, z. B. ausgehend von Phosphatidylcholin, in Microsphären, in Nanosphären oder auch in Kapseln aus einer geeigneten Matrix, z. B. aus natürlichen oder synthetischen Wachsen, beispielsweise Bienenwachs, Carnaubawachs, Silicon wachs oder Stearylalkohol, Eicosanol, Cetylalkohol, Stearin oder Paraffinwachs oder aus Gelatine, eingearbeitet werden. Eine weitere Ausführungsform besteht darin, dass die die 2-Hydrazino-1,3-thiazole der allgemeinen Formel I vorher mit Komplexbildnern, beispielsweise mit Cyclodextrinen oder Cyclodextrinderivaten, bevorzugt Methylcyclodextrin, komplexiert werden.To prepare the preparations according to the invention, in a further Embodiment also the 2-hydrazino-1,3-thiazoles of the general formula I. previously in liposomes, e.g. B. starting from phosphatidylcholine, in microspheres, in Nanospheres or in capsules made of a suitable matrix, e.g. B. from natural or synthetic waxes, for example beeswax, carnauba wax, silicone wax or stearyl alcohol, eicosanol, cetyl alcohol, stearin or paraffin wax or made of gelatin. Another embodiment exists in that the 2-hydrazino-1,3-thiazoles of the general formula I previously with Complexing agents, for example with cyclodextrins or cyclodextrin derivatives, preferably methylcyclodextrin, can be complexed.
Die erfindungsgemäßen kosmetischen und dermatologischen Zubereitungen können kosmetische Hilfs- und Zusatzstoffe enthalten, wie sie üblicherweise in solchen Zubereitungen vewendet werden, z. B. Sonnenschutzmittel (z. B. organische oder anorganische Lichtfiltersubstanzen, bevorzugt Mikropigmente), Konservierungs mittel, Bakterizide, Fungizide, Viruzide, Kühlwirkstoffe, Pflanzenextrakte, entzün dungshemmende Wirkstoffe, die Wundheilung beschleunigende Stoffe (z. B. Chitin oder Chitosan und dessen Derivate), filmbildende Substanzen (z. B. Polyvinylpyrrolidone oder Chitosan oder dessen Derivate), gebräuchliche Antioxidantien, Vitamine (z. B. Vitamin C und Derivate, Tocopherole und Derivate, Vitamin A und Derivate), 2-Hydroxycarbonsäuren (z. B. Citronensäure, Äpfelsäure, L-, D-, oder d1- Milchsäure), Hautaufhellungsmittel (z. B. Kojisäure, Hydrochinon oder Arbutin), Hautfärbungsmittel (z. B. Walnussextrakte oder Dihydroxyaceton), Parfüme, Sub stanzen zum Verhindern des Schäumens, Farbstoffe, Pigmente, die eine färbende Wirkung haben, Verdickungsmittel, oberflächenaktive Substanzen, Emulgatoren, weichmachende, anfeuchtende und/oder feuchthaltende Substanzen (z. B. Glycerin oder Harnstoff), Fette, Öle, ungesättigte Fettsäuren oder deren Derivate (z. B. Linol säure, α-Linolensäure, γ-Linolensäure oder Arachidonsäure und deren jeweiligen natürlichen oder synthetischen Ester), Wachse oder andere übliche Bestandteile einer kosmetischen oder dermatologischen Formulierung wie Alkohole, Polyole, Poly mere, Schaumstabilisatoren, Elektrolyte, organische Lösungsmittel, Silikonderivate oder Chelatbildner (z. B. Ethylendiamintetraessigsäure und Derivate).The cosmetic and dermatological preparations according to the invention can contain cosmetic auxiliaries and additives, as is usually the case in such Preparations are used, e.g. B. sunscreen (e.g. organic or inorganic light filter substances, preferably micropigments), preservatives medium, bactericides, fungicides, virucides, cooling agents, plant extracts, inflammable anti-aging agents, substances that accelerate wound healing (e.g. chitin or chitosan and its derivatives), film-forming substances (e.g. polyvinylpyrrolidones or chitosan or its derivatives), common antioxidants, Vitamins (e.g. vitamin C and derivatives, tocopherols and derivatives, vitamin A and Derivatives), 2-hydroxycarboxylic acids (e.g. citric acid, malic acid, L-, D-, or d1- Lactic acid), skin lightening agents (e.g. kojic acid, hydroquinone or arbutin), Skin colorants (e.g. walnut extracts or dihydroxyacetone), perfumes, sub die cut to prevent foaming, dyes, pigments, a coloring Have an effect, thickeners, surface-active substances, emulsifiers, softening, moisturizing and / or moisturizing substances (e.g. glycerin or urea), fats, oils, unsaturated fatty acids or their derivatives (e.g. Linol acid, α-linolenic acid, γ-linolenic acid or arachidonic acid and their respective natural or synthetic esters), waxes or other common components of a cosmetic or dermatological formulation such as alcohols, polyols, poly mers, foam stabilizers, electrolytes, organic solvents, silicone derivatives or chelating agents (e.g. ethylenediaminetetraacetic acid and derivatives).
Die jeweils einzusetzenden Mengen an Mengen an kosmetischen oder dermatologi schen Hilfs- und Zusatzstoffen und Parfüm können in Abhängikeit von der Art des jeweiligen Produkts vom Fachmann durch einfaches Ausprobieren leicht ermittelt werden.The amounts of cosmetic or dermatological amounts to be used in each case auxiliaries and additives and perfume can depend on the type of each product is easily determined by a specialist simply by trying it out become.
Zur Anwendung werden die erfindungsgemäßen kosmetischen oder dermatolo gischen Zubereitungen, enthaltend 2-Hydrazino-1,3-thiazole der allgemeinen Formel I, in der für Kosmetika üblichen Weise auf die Haut und/oder die Haare in ausreichender Menge aufgebracht.The cosmetic or dermatolo according to the invention are used Mixtures containing 2-hydrazino-1,3-thiazoles of the general Formula I, in the usual way for cosmetics on the skin and / or hair in sufficient amount applied.
Bevorzugt können die erfindungsgemäßen kosmetischen oder dermatologischen Zubereitungen, enthaltend 2-Hydrazino-1,3-thiazole der allgemeinen Formel I oder deren Salze, auch Wirkstoffe zur Hautaufhellung enthalten. Insbesondere können die erfindungsgemäßen topischen kosmetischen Mittel auch Benzaldoxime mit min destens einer aromatischen Hydroxy- oder Alkoxygruppe, Kojisäure, Kojisäure derivate, Ascorbinsäure, Ascorbinsäurederivate, Hydrochinon, Hydrochinonderivate, schwefelhaltigen Moleküle (z. B. Glutathion oder Cystein) oder andere synthe tische oder natürliche Wirkstoffe zur Hautaufhellung enthalten, wobei letztere auch in Form eines Extrakts aus Pflanzen (z. B. Tocopherole und Derivate, Arbutin (z. B. aus Bearberry-Extrakt), Aloesin (z. B. aus Aloe-Extrakt), Grapefruit-Extrakt und Reis-Extrakt) verwendet werden können.The cosmetic or dermatological according to the invention can preferably Preparations containing 2-hydrazino-1,3-thiazoles of the general formula I or their salts, also contain active ingredients for skin lightening. In particular can the topical cosmetic compositions according to the invention also benzaldoximes with min at least one aromatic hydroxy or alkoxy group, kojic acid, kojic acid derivatives, ascorbic acid, ascorbic acid derivatives, hydroquinone, hydroquinone derivatives, sulfur-containing molecules (e.g. glutathione or cysteine) or other synthe contain tables or natural active ingredients for skin lightening, the latter also in the form of an extract from plants (e.g. tocopherols and derivatives, arbutin (e.g. from Bearberry extract), Aloesin (e.g. from Aloe extract), Grapefruit extract and Rice extract) can be used.
Die Menge der vorgenannten beispielhaften Wirkstoffe zur Hautaufhellung (eine oder mehrere Verbindungen) kann in den erfindungsgemäßen kosmetischen oder dermatologischen Zubereitungen 0,001 bis 30 Gew.-%, bevorzugt 0,001 bis 20 Gew-%, besonders bevorzugt 0,001 bis 5 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung, betragen.The amount of the aforementioned exemplary active ingredients for skin lightening (a or more compounds) can be used in the cosmetic or dermatological preparations 0.001 to 30% by weight, preferably 0.001 to 20% by weight, particularly preferably 0.001 to 5% by weight, based on the total weight the preparation.
Besonders bevorzugt sind solche kosmetischen oder dermatologischen Zube reitungen, die gleichzeitig in Form eines Sonnenschutzmittels vorliegen. Diese ent halten neben einem wirksamen Anteil der 2-Hydrazino-1,3-thiazole der allgemeinen Formel I auch Sonnenschutzsubstanzen, bevorzugt organische oder anorganische Lichtfiltersubstanzen, insbesondere Mikropigmente. Die erfindungsgemäßen Haut aufhellungsmittel können aber auch UVA- und/oder UVB-Filtersubstanzen ent halten, wobei die Gesamtmenge an Filtersubstanzen 0,1 bis 30 Gew.-%, vorzugs weise 0,5 bis 10 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitungen, betragen kann, wobei man Sonnenschutzmitteln für Haut und Haar erhält. Als UV- Filtersubstanzen können beispielsweise 3-Benzylidencampherderivate (z. B. 3-(4- Methylbenzyliden)-d1-campher), Aminobenzoesäurederivate (z. B. 4-(N,N-Di methylamino)benzoesäure-2-ethylhexylester oder Menthylanthranilat), 4-Methoxy cinnamate (z. B. 2-Ethylhexyl-p-methoxycinnamat oder Isoamyl-p-methoxycinna mat), Benzophenone (z. B. 2-Hydroxy-4-methoxybenzophenon), ein- oder mehrfach sulfonierte UV-Filter [z. B. 2-Phenylbenzimidazol-5-sulfonsäure, Sulisobenzone oder 1,4-Bis(benzimidazolyl)-benzol-4,4',6,6' -tetrasulfonsäure bzw. 3,3'-(1,4-Phe nylendimethyliden)-bis-(7,7-dimethyl-2-oxo-bicyclo-[2,2,1]heptan-1-methansulfon säure) und deren Salze], Salicylate (z. B. 2-Ethylhexylsalicylat oder Homomenthyl salicylat), Triazine {z. B. 2,4-Bis-[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4- methoxyphenyl)-1,3,5-triazin, 4,4'-([6-([(1,1-dimethylethyl)-aminocarbonyl]- phenylamino)-1,3,5-triazin-2,4-diyl]diimino)bisbenzoesäurebis-(2-ethylhexyl)- ester)}, 2-Cyanopropensäurederivate (z. B. 2-Ethylhexyl-2-cyano-3,3-diphenyl-2- propenoat), Dibenzoylderivate (z. B. 4-tert-Butyl-4'-methoxydibenzoylmethan), polymergebundende UV-Filter (z. B. Polymer von N-[2-(bzw. 4)-(2-Oxo-3- bornyliden)methyl]benzylacrylamid) oder Pigmente (z. B. Titandioxide, Zirkondi oxide, Eisenoxide, Siliciumdioxide, Manganoxide, Aluminiumoxide, Ceroxide oder Zinkoxide) verwendet werden.Such cosmetic or dermatological accessories are particularly preferred riding that is also in the form of a sunscreen. This ent hold in addition to an effective portion of the 2-hydrazino-1,3-thiazoles of the general Formula I also sunscreen substances, preferably organic or inorganic Light filter substances, in particular micropigments. The skin according to the invention Whitening agents can also entail UVA and / or UVB filter substances hold, the total amount of filter substances 0.1 to 30 wt .-%, preferably 0.5 to 10% by weight, based on the total weight of the preparations, can be, whereby one obtains sunscreens for skin and hair. As UV Filter substances can, for example, 3-benzylidene camphor derivatives (e.g. 3- (4- Methylbenzylidene) -d1-camphor), aminobenzoic acid derivatives (e.g. 4- (N, N-Di methylamino) 2-ethylhexyl benzoate or menthyl anthranilate), 4-methoxy cinnamates (e.g. 2-ethylhexyl p-methoxycinnamate or isoamyl p-methoxycinna mat), benzophenones (e.g. 2-hydroxy-4-methoxybenzophenone), one or more times sulfonated UV filters [e.g. B. 2-phenylbenzimidazole-5-sulfonic acid, Sulisobenzone or 1,4-bis (benzimidazolyl) benzene-4,4 ', 6,6'-tetrasulfonic acid or 3,3' - (1,4-Phe nylendimethyliden) bis (7,7-dimethyl-2-oxo-bicyclo [2,2,1] heptane-1-methanesulfonic acid) and their salts], salicylates (e.g. 2-ethylhexyl salicylate or homomenthyl salicylate), triazines {e.g. B. 2,4-bis- [4- (2-ethylhexyloxy) -2-hydroxyphenyl] -6- (4- methoxyphenyl) -1,3,5-triazine, 4,4 '- ([6 - ([(1,1-dimethylethyl) aminocarbonyl] - phenylamino) -1,3,5-triazine-2,4-diyl] diimino) bisbenzoesäurebis- (2-ethylhexyl) - ester)}, 2-cyanopropenoic acid derivatives (e.g. 2-ethylhexyl-2-cyano-3,3-diphenyl-2- propenoate), dibenzoyl derivatives (e.g. 4-tert-butyl-4'-methoxydibenzoylmethane), polymer-bound UV filters (e.g. polymer of N- [2- (or. 4) - (2-oxo-3- bornylidene) methyl] benzylacrylamide) or pigments (e.g. titanium dioxide, zirconium di oxides, iron oxides, silicon oxides, manganese oxides, aluminum oxides, cerium oxides or Zinc oxides) can be used.
In einer weiteren bevorzugten Ausführungsform der Erfindung sind in den erfindungsgemäßen Zubereitungen neben den erfindungsgemäßen 2-Hydrazino-1,3- thiazolen auch andere Antioxidantien oder Radikalfänger enthalten. Insbesondere können als andere Antioxidantien alle für die erfindungsgemäßen Anwendungen geeigneten oder gebräuchlichen Antioxidantien verwendet werden. Vorteilhaft werden die Antioxidantien ausgewählt aus der Gruppe bestehend aus Aminosäuren (z. B. Glycin, Histidin, 3,4-Dihydroxyphenylalanin, Tyrosin, Tryptophan) und deren Derivate, Imidazole (z. B. Urocaninsäure) und deren Derivate, Peptide (D,L- Carnosin, D-Carnosin, L-Carnosin, Anserin) und deren Derivate, Carotinoide, Carotine (z. B. α-Carotin, β-Carotin, Lycopin) und deren Derivate, Chlorogensäure und deren Derivate, Liponsäure und deren Derivate, Aurothioglucose, Propylthiouracil und andere Thiole (z. B. Thioredoxin, Glutathion, Cystein, Cystin, Cystamin und deren Glycosyl- und N-Acylderivate oder deren Alkylester) sowie deren Salze, Dilaurylthiodipropionat, Distearylthiodipropionat, Thiodipropionsäure und deren Derivate sowie Phenolsäureamide phenolischer Benzylamine (z. B. Homovanillinsäure-, 3,4-Dihydroxyphenylessigsäure-, Ferulasäure-, Sinapinsäure-, Kaffeesäure-, Dihydroferulasäure-, Dihydrokaffeesäure-, Vanillomandelsäure- oder 3,4-Dihydroxymandelsäureamide des 3,4-Dihydroxybenzyl-, 2,3,4-Trihydroxy benzyl- bzw. 3,4,5-Trihydroxybenzylamins), ferner (Metall-)chelatoren (z. B. 2- Hydroxyfettsäuren, Phytinsäure, Lactoferrin), Huminsäure, Gallensäuren, Gallen extrakte, Bilirubin, Biliverdin, Folsäure und deren Derivate, Ubichinon und Ubichinol und deren Derivate, Vitamin C und dessen Derivate (z. B. Ascorbylpalmitat, Magnesiumascorbylphosphat, Ascorbylacetat), Tocopherole und Derivate (z. B. Vitamin-E-Acetat), Vitamin A und Derivate (z. B. Vitamin-A-Palmitat), Rutin säure und deren Derivate, Flavonoide (z. B. Quercetin, α-Glucosylrutin) und deren Derivate, Phenolsäuren (z. B. Gallussäure, Ferulasäure) und deren Derivate (z. B. Gallussäurepropylester, -ethylester, -octylester), Furfurylidenglucitol, Dibutyl hydroxytoluol, Butylhydroxyanisol, Harnsäure und deren Derivate, Mannose und deren Derivate, Zink und dessen Derivate (z. B. ZnO, ZnSO4), Selen und dessen Derivate (z. B. Selenomethionin), Stilbene und deren Derivate (z. B. Stilbenoxid, Resveratrol) und die erfindungsgemäß geeigneten Derivate dieser genannten Wirk stoffe.In a further preferred embodiment of the invention, in addition to the 2-hydrazino-1,3-thiazoles according to the invention, the preparations according to the invention also contain other antioxidants or free radical scavengers. In particular, all antioxidants suitable or customary for the applications according to the invention can be used as other antioxidants. The antioxidants are advantageously selected from the group consisting of amino acids (e.g. glycine, histidine, 3,4-dihydroxyphenylalanine, tyrosine, tryptophan) and their derivatives, imidazoles (e.g. urocanic acid) and their derivatives, peptides (D, L-carnosine, D-carnosine, L-carnosine, anserine) and their derivatives, carotenoids, carotenes (e.g. α-carotene, β-carotene, lycopene) and their derivatives, chlorogenic acid and its derivatives, lipoic acid and its derivatives, Aurothioglucose, propylthiouracil and other thiols (e.g. thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl and N-acyl derivatives or their alkyl esters) as well as their salts, dilaurylthiodipropionate, distearylthiodipropionate, thiodipropolic acid and their amidophenol phenolic acid and their derivatives B. Homovanillic acid, 3,4-dihydroxyphenylacetic acid, ferulic acid, sinapic acid, caffeic acid, dihydroferulic acid, dihydrocaffeic acid, vanillomandelic acid or 3,4-dihydroxymandelic acid ami de of 3,4-dihydroxybenzyl-, 2,3,4-trihydroxy benzyl- or 3,4,5-trihydroxybenzylamine), further (metal) chelators (e.g. B. 2-hydroxy fatty acids, phytic acid, lactoferrin), humic acid, bile acids, bile extracts, bilirubin, biliverdin, folic acid and its derivatives, ubiquinone and ubiquinol and their derivatives, vitamin C and its derivatives (e.g. ascorbyl palmitate, magnesium ascorbyl phosphate, ascorbyl acetate) , Tocopherols and derivatives (e.g. vitamin E acetate), vitamin A and derivatives (e.g. vitamin A palmitate), rutinic acid and its derivatives, flavonoids (e.g. quercetin, α-glucosylrutin) and their derivatives, phenolic acids (e.g. gallic acid, ferulic acid) and their derivatives (e.g. propyl gallate, ethyl ester, octyl ester), furfurylidene glucitol, dibutyl hydroxytoluene, butylated hydroxyanisole, uric acid and its derivatives, mannose and their derivatives, zinc and its derivatives (e.g. ZnO, ZnSO 4 ), selenium and its derivatives (e.g. selenomethionine), stilbenes and their derivatives (e.g. stilbene oxide, resveratrol) and the derivatives of these active substances which are suitable according to the invention.
Die Menge der vorgenannten anderen Antioxidantien (eine oder mehrere Verbin dungen), die mit den erfindungsgemäßen 2-Hydrazino-1,3-thiazolen nicht identisch sind, in den erfindungsgemäßen Zubereitungen beträgt vorzugsweise 0,0001 bis 30 Gew.-%, besonders bevorzugt 0,01 bis 10 Gew.-%, insbesondere bevorzugt 0,01 bis 5 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitungen.The amount of the aforementioned other antioxidants (one or more compounds dungen), which are not identical to the 2-hydrazino-1,3-thiazoles according to the invention are in the preparations according to the invention is preferably 0.0001 to 30% by weight, particularly preferably 0.01 to 10% by weight, particularly preferably 0.01 up to 5% by weight, based on the total weight of the preparations.
Außer den erfindungsgemäßen 2-Hydrazino-1,3-thiazolen können selbstverständlich mehrere weitere Antioxidantien eingesetzt werden.In addition to the 2-hydrazino-1,3-thiazoles according to the invention can of course several other antioxidants are used.
Die Lipidphase in den erfindungsgemäßen kosmetischen oder dermatologischen Zubereitungen, enthaltend 2-Hydrazino-1,3-thiazole der allgemeinen Formel I oder deren Salze, kann vorteilhaft gewählt werden aus folgenden Substanzgruppen: Mineralöle (vorteilhaft Paraffinöl), Mineralwachse, Kohlenwasserstoffe (vorteilhaft Squalan oder Squalen), synthetische oder halbsynthetische Triglyceridöle (z. B. Triglyceride der Caprin- oder Caprylsäure), natürliche Öle (z. B. Rizinusöl, Oliven öl, Sonnenblumenöl, Sojaöl, Erdnussöl, Rapsöl, Mandelöl, Palmöl, Kokusöl, Palm kernöl, Borretschsamenöl und dergleichen mehr), natürliche Esteröle (z. B. Jojoba öl), synthetische Esteröle (bevorzugt Ester von gesättigten und/oder ungesättigten, linearen und/oder verzweigten Alkancarbonsäuren von 3 bis 30 C-Atomen mit ge sättigten und/oder ungesättigten, linearen und/oder verzweigten Alkoholen mit 3 bis 30 C-Atomen und Ester von aromatischen Carbonsäuren mit gesättigten und/oder ungesättigten, linearen und/oder verzweigten Alkoholen mit 3 bis 30 C-Atomen, insbesondere ausgewählt aus der Gruppe Isopropylmyristat, Isopropylstearat, Iso propylpalmitat, Isopropyloleat, n-Butylstearat, n-Hexyllaurat, n-Decyllaurat, Iso octylstearat, Isononylstearat, Isononylisononanoat, 2-Ethylhexylpalmitat, 2-Ethyl hexyllaureat, 2-Hexyldecylstearat, 2-Octyldecylpalmitat, Oleyloleat, Oleylerucat, Erucyloleat, Erucylerucat sowie synthetische oder natürliche Gemische solcher Ester), Fette, Wachse und andere natürliche und synthetische Fettkörper, vor zugsweise Ester von Fettalkoholen mit Alkoholen niedriger C-Zahl (z. B. mit Isopropanol, Propylenglycol oder Glycerin) oder Ester von Fettalkoholen mit Alkansäuren niedriger C-Zahl oder mit Fettsäuren, Alkylbenzoate (z. B. Gemische von n-Dodecyl-, n-Tridecyl-, n-Tetradecyl- und n-Pentadecylbenzoat) sowie cyclische oder lineare Silikonöle (wie z. B. Dimethylpolysiloxane, Diethylpoly siloxane, Diphenylpolysiloxane sowie Mischformen daraus).The lipid phase in the cosmetic or dermatological invention Preparations containing 2-hydrazino-1,3-thiazoles of the general formula I or their salts can advantageously be selected from the following groups of substances: Mineral oils (advantageous paraffin oil), mineral waxes, hydrocarbons (advantageous Squalane or squalene), synthetic or semi-synthetic triglyceride oils (e.g. Triglycerides of capric or caprylic acid), natural oils (e.g. castor oil, olives oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, palm kernel oil, borage seed oil and the like), natural ester oils (e.g. jojoba oil), synthetic ester oils (preferably esters of saturated and / or unsaturated, linear and / or branched alkane carboxylic acids of 3 to 30 carbon atoms with ge saturated and / or unsaturated, linear and / or branched alcohols with 3 to 30 carbon atoms and esters of aromatic carboxylic acids with saturated and / or unsaturated, linear and / or branched alcohols with 3 to 30 C atoms, especially selected from the group of isopropyl myristate, isopropyl stearate, iso propyl palmitate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl laurate, iso octyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethyl hexyl laurate, 2-hexyldecyl stearate, 2-octyldecyl palmitate, oleyl oleate, olerlerucate, Erucyl oleate, erucylerucate and synthetic or natural mixtures thereof Esters), fats, waxes and other natural and synthetic fat bodies preferably esters of fatty alcohols with alcohols with a low C number (e.g. with Isopropanol, propylene glycol or glycerin) or esters of fatty alcohols Low carbon number alkanoic acids or with fatty acids, alkyl benzoates (e.g. mixtures of n-dodecyl, n-tridecyl, n-tetradecyl and n-pentadecyl benzoate) and cyclic or linear silicone oils (such as dimethylpolysiloxanes, diethylpoly siloxanes, diphenylpolysiloxanes and mixed forms thereof).
Die wässrige Phase der erfindungsgemäßen kosmetischen oder dermatologischen Zubereitungen, enthaltend 2-Hydrazino-1,3-thiazole der allgemeinen Formel I oder deren Salze, enthält gegebenenfalls vorteilhaft Alkohole, Diole oder Polyole niedriger C-Zahl, sowie deren Ether, vorzugsweise Ethanol, Isopropanol, Propylen glycol, Glycerin, Ethylenglycol, Ethylenglycolmonoethyl- oder -monobutylether, Propylenglycolmonomethylether-, -monoethyl- oder -monobutylether, Diethylen glycolmonomethyl- oder monoethylether und analoge Produkte, ferner Alkohole niedriger C-Zahl, z. B. Ethanol, Isopropanol, 1,2-Propandiol, Glycerin sowie ins besondere ein oder mehrere Verdickungsmittel, welches oder welche vorteilhaft ausgewählt werden können aus der Gruppe Siliciumdioxid, Aluminiumsilikate, Polysaccharide bzw. deren Derivate, z. B. Hyaluronsäure, Xanthangummi, Hydroxy propylmethylcellulose, besonders vorteilhaft aus der Gruppe der Polyacrylate, bevorzugt ein Polyacrylat aus der Gruppe der sogenannten Carbopole, jeweils einzeln oder in Kombination oder aus der Gruppe der Polyurethane. The aqueous phase of the cosmetic or dermatological invention Preparations containing 2-hydrazino-1,3-thiazoles of the general formula I or their salts, optionally advantageously contains alcohols, diols or polyols low C number, and their ethers, preferably ethanol, isopropanol, propylene glycol, glycerin, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, Propylene glycol monomethyl ether, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analog products, also alcohols low C number, e.g. As ethanol, isopropanol, 1,2-propanediol, glycerin and ins special one or more thickeners, which or which advantageous can be selected from the group silicon dioxide, aluminum silicates, Polysaccharides or their derivatives, e.g. B. hyaluronic acid, xanthan gum, hydroxy propylmethyl cellulose, particularly advantageously from the group of polyacrylates, preferably a polyacrylate from the group of the so-called carbopoles, in each case individually or in combination or from the group of polyurethanes.
Insbesondere bevorzugt ist die Verwendung der erfindungsgemäßen Zubereitungen zum Schutz von Geweben und Zellen von Säugern vor oxidativer Beanspruchung. Die erfindungsgemäßen kosmetischen oder dermatologischen Zubereitungen dienen vor allem dem Schutz der der Haut, der Haare und/oder der Nägel des Menschen, vor oxidativer Beanspruchung und dem schädlichen Einfluss von Radikalen.The use of the preparations according to the invention is particularly preferred to protect mammalian tissues and cells from oxidative stress. The cosmetic or dermatological preparations according to the invention serve especially the protection of human skin, hair and / or nails, against oxidative stress and the harmful influence of radicals.
Ebenso umfasst die vorliegende Erfindung auch ein Verfahren zum Schutze kosmeti scher, dermatologischer sowie der Ernährung oder dem Genuss dienender Zube reitungen gegen Oxidation oder Photooxidation, wobei es sich bei diesen Zube reitungen z. B. um Zubereitungen zur Behandlung, zum Schutz und Pflege der Haut, der Nägel oder der Haare oder auch Nahrungs- und Genussmittel handeln kann, deren Bestandteile Stabilitätsprobleme aufgrund von Oxidation bzw. Photooxidation bei der Lagerung mit sich bringen, dadurch gekennzeichnet, dass erfindungsgemäßen Zubereitungen einen wirksamen Gehalt an erfindungsgemäßen 2-Hydrazino-1,3-thi azolen aufweisen. The present invention also includes a method for protecting cosmetics shear, dermatological and food or pleasure accessories against oxidation or photo-oxidation, these accessories horse riding z. B. preparations for the treatment, protection and care of the skin, who can trade nails or hair or food and beverages, their components stability problems due to oxidation or photooxidation bring with it in storage, characterized in that according to the invention Preparations an effective content of 2-hydrazino-1,3-thi according to the invention have azoles.
Teil A wurde gemischt und auf 80°C erhitzt. Teil B wurde gemischt und auf 90°C erhitzt und unter Rühren zu Teil A gegeben. Für Teil C wurde Carbopol in Wasser sorgfältig dispergiert und mit Natronlauge neutralisiert (pH 6,9). Teil C wurde dann bei 60°C zur Mischung aus den Teilen A und B gegeben. Teil D wurde zu der Mi schung aus den Teilen A, B, und C bei Raumtemperatur hinzugefügt.Part A was mixed and heated to 80 ° C. Part B was mixed and heated to 90 ° C heated and added to Part A with stirring. For part C, Carbopol was in water carefully dispersed and neutralized with sodium hydroxide solution (pH 6.9). Part C then became added at 60 ° C to the mixture of parts A and B. Part D became the Mi added from parts A, B, and C at room temperature.
Für Teil A wurden alle Substanzen bis auf das Zinkoxid auf 85°C erhitzt und das Zinkoxid in der Mischung sorgfältig dispergiert. Die Komponenten des Teils B wurde gemischt, auf 85°C erhitzt und unter Rühren zu Teil A gegeben. Zu der Mischung aus den Teilen A und B wurde Teil C zugegeben und anschließend die Mi schung mit einem Dispergierwerkzeug homogenisiert.For part A, all substances except the zinc oxide were heated to 85 ° C and that Zinc oxide carefully dispersed in the mixture. The components of part B was mixed, heated to 85 ° C and added to Part A with stirring. To the mix from parts A and B part C was added and then Mi homogenized with a dispersing tool.
Für Teil A wurden alle Substanzen bis auf das Titandioxid gemischt und auf 85°C erhitzt; in die Mischung wurde das Titandioxid sorgfältig eindispergiert. Für Teil B wurden bis auf Veegum und Natrosol alle Substanzen gemischt, auf 90°C erhitzt, Natrosol und Veegum eindispergiert und die Mischung unter Rühren zu Teil A ge geben. Zu der Mischung aus den Teilen A und B wurde Teil C zugegeben und an schließend die Mischung mit einem Dispergierwerkzeug homogenisiert. For Part A, all substances were mixed except for the titanium dioxide and to 85 ° C heated; the titanium dioxide was carefully dispersed into the mixture. For part B except Veegum and Natrosol, all substances were mixed, heated to 90 ° C, Dispersed Natrosol and Veegum and the mixture with stirring to part A ge give. Part C was added to the mixture of parts A and B and then finally homogenize the mixture with a dispersing tool.
Teil A wurde auf 85°C erhitzt. Carbopol und Keltrol wurden in die restlichen Be standteile kalt eindispergiert, die Mischung auf 85°C erwärmt und zu Teil A gege ben. Teil C wurde sofort bei 80°C zu der Mischung aus den Teilen A und B gege ben und 5 min mit einem Dispergierwerkzeug homogensiert. Teil D wurde schließ lich bei Raumtemperatur zugegeben und die Mischung mit einem Dispergierwerk zeug homogenisiert.Part A was heated to 85 ° C. Carbopol and Keltrol were added to the rest of the Be dispersed cold constituents, the mixture heated to 85 ° C and added to part A. ben. Part C was immediately added to the mixture of parts A and B at 80 ° C ben and homogenized for 5 min with a dispersing tool. Part D was closed Lich added at room temperature and the mixture with a disperser homogenized stuff.
Die Aktivität der beispielhaften Verbindungen als Radikalfänger wurde mit der herkömmlicher Radikalfänger verglichen. Dabei wurde der DPPH-(1,1-Diphenyl-2- picryl-hydrazyl)-Test zur Beseitigung von Radikalen angewendet.The activity of the exemplary compounds as radical scavengers was compared with the compared to conventional radical scavengers. The DPPH- (1,1-diphenyl-2- Picryl-hydrazyl) test applied to remove radicals.
DPPH wurde in Methanol zu einer Konzentration von 100 µmol/l gelöst. Eine Reihe
von Verdünnungen der beispielhaften Verbindungen, Vitamin C, α-Tocopherol und
Dibutylhydroxytoluol wurden in Methanol hergestellt. Methanol diente als Kontrolle.
2500 µl der DPPH-Lösung wurden mit 500 µl einer jeden Testlösung gemischt und
die Abnahme der Absorption bei 515 nm solange abgelesen, bis die Abnahme kleiner
als 2% pro Stunde war. Die Aktivität der Testsubstanzen als Radikalfänger wurde
nach folgender Gleichung berechnet:
Aktiv, als Radikalfänger (%) = 100 - (Absorption der Testverbindungen)/(Absorption
der Kontrolle) × 100.
DPPH was dissolved in methanol to a concentration of 100 µmol / l. A number of dilutions of the exemplary compounds, vitamin C, α-tocopherol and dibutylhydroxytoluene were made in methanol. Methanol served as a control. 2500 μl of the DPPH solution were mixed with 500 μl of each test solution and the decrease in absorption at 515 nm was read until the decrease was less than 2% per hour. The activity of the test substances as radical scavengers was calculated according to the following equation:
Active, as radical scavenger (%) = 100 - (absorption of test compounds) / (absorption of control) × 100.
Aus der Aktivität als Radikalfänger (%) in einer Reihe von Verdünnungen von Test verbindungen wurde für jede Testverbindung die effektive relative Konzentration EC50 (bezogen auf die anfangs vorhandene Konzentration an DPPH, EC = c (Test verbindung)/c(DPPH)) einer Testverbindung berechnet, bei der das Radikal DPPH um 50% beseitigt wurde. Die Ergebnisse sind in Tabelle 1 dargestellt:From the activity as radical scavenger (%) in a series of dilutions of test compounds, the effective relative concentration EC 50 (based on the initially existing concentration of DPPH, EC = c (test compound) / c (DPPH)) became one for each test compound Test compound calculated with the radical DPPH removed by 50%. The results are shown in Table 1:
Die Aktivität der beispielhaften Verbindungen nach den als Antioxidantien wurde mit der herkömmlicher Antioxidantien verglichen. Als Testsystem wurde die be schleunigte Autoxidation von Lipiden durch Luft mit oder ohne Antioxidans mit Hilfe der Rancimat-Apparatur angewendet (Rancimat ist ein eingetragenes Warenzeichen der Metrohm AG, Herisau, Schweiz). The activity of the exemplary compounds has been shown to be that of antioxidants compared to that of conventional antioxidants. The be accelerated autoxidation of lipids by air with or without antioxidant with Using the Rancimat apparatus applied (Rancimat is a registered Trademark of Metrohm AG, Herisau, Switzerland).
Die beispielhaften Verbindungen, Vitamin C, α-Tocopherol und Dibutylhydroxy toluol wurden in Methanol oder Aceton gelöst und von der jeweiligen Testlösung 100 µl zu einer vorbereiteten Ölprobe von 3 g gegeben. In eine Kontrollprobe wurde nur Lösungsmittel gegeben. Durch die aufgeheizte, die Testlösung enthaltende Öl probe wurde ein konstanter, trockener Luftstrom (20 l/h) geblasen und die flüchtigen Oxidationsprodukte (vorwiegend kurzkettige Fettsäuren wie Ameisen- oder Essig säure) in einer Vorlage mit Wasser gesammelt. Die Leitfähigkeit dieser wässrigen Lösung wurde kontinuierlich gemessen und dokumentiert. Die Oxidation von (unge sättigten) Fetten verläuft dabei eine Zeitlang nur sehr langsam und steigt dann plötzlich stark an. Die Zeit bis zum Anstieg wird als Induktionsperiode (IP) be zeichnet.The exemplary compounds, vitamin C, α-tocopherol and dibutylhydroxy toluene were dissolved in methanol or acetone and from the respective test solution Add 100 µl to a prepared 3 g oil sample. Was in a control sample only given solvents. By the heated oil containing the test solution A constant, dry air flow (20 l / h) was blown into the sample and the volatile Oxidation products (mainly short-chain fatty acids such as ants or vinegar acid) collected in a template with water. The conductivity of this watery Solution was continuously measured and documented. The oxidation of (unsung saturated) fats run very slowly for a while and then increase suddenly strong. The time to rise is called the induction period (IP) records.
Nach der folgenden Gleichung wurde der antioxidative Index (AOI) erhalten:
The antioxidative index (AOI) was obtained according to the following equation:
AOI = IP(mit Testlösung)/IP(Kontrollprobe).AOI = IP (with test solution) / IP (control sample) .
Die Ergebnisse für die Experimente in Sojaöl bei 100°C und bei 80°C in Squalen, dass über Alumina Typ N gereinigt und mit 1 ppm α-Tocopherol stabilisiert wurde, sind in Tabelle 2 dargestellt: The results for the experiments in soybean oil at 100 ° C and at 80 ° C in squalene, that was cleaned over alumina type N and stabilized with 1 ppm α-tocopherol, are shown in Table 2:
Claims (10)
oder deren Salze,
wobei
X ein Stickstoffatom oder ein substituiertes Kohlenstoffatom C-Q2 darstellt,
und
entweder
Q1 und Q2 unabhängig voneinander Wasserstoffatome,
gegebenenfalls Hydroxy- oder Alkyloxy-substituierte unverzweigte, verzweigte oder cyclische Alkyl-, Alkenyl-, 1-Oxoalkyl oder 1- Oxoalkenylgruppen mit 1 bis 18 Kohlenstoffatomen,
gegebenenfalls substituierte Arylgruppen mit 6 bis 15 Kohlenstoff atomen,
gegebenenfalls substituierte Heterocyclylgruppen mit 2 bis 15 Kohlen stoffatomen und mindestems einem Heteroatom ausgewählt aus der Gruppe Sauerstoff, Stickstoff oder Schwefel,
gegebenenfalls substituierte Arylalkyl- oder Aryl-1-oxoalkylgruppen von 7 bis 16 Kohlenstoffatomen,
Halogenatome, Nitrogruppen oder
Gruppen -COOR4, -OR4, -NR4R5, -SO2OR5, -SO2NR4R5 oder -PO(OR4)(OR5) darstellen,
oder
Q1 und Q2 zusammen einen Rest der allgemeinen Formel (II)
darstellen,
wobei
X1, X2 und X3 unabhängig voneinander entweder Stickstoffatome oder Kohlenstoffatome mit den Resten R1, R2 bzw. R3 darstellen,
und
R1, R2 und R3 unabhängig voneinander Wasserstoffatome,
gegebenenfalls Hydroxy- oder Alkyloxy-substituierte unverzweigte, verzweigte oder cyclische Alkyl-, Alkenyl-, 1-Oxoalkyl oder 1-Oxo alkenylgruppen mit 1 bis 18 Kohlenstoffatomen,
gegebenenfalls substituierte Arylgruppen mit 6 bis 15 Kohlenstoff atomen,
gegebenenfalls substituierte Heterocyclylgruppen mit 2 bis 15 Kohlen stoffatomen und mindestems einem Heteroatom ausgewählt aus der Gruppe Sauerstoff, Stickstoff oder Schwefel,
gegebenenfalls substituierte Arylalkyl- oder Aryl-1-oxoalkylgruppen von 7 bis 16 Kohlenstoffatomen,
Halogenatome, Nitrogruppen oder
Gruppen -COOR4, -OR4, -NR4R5, -SO2OR4, -SO2NR4R5 oder -PO(OR4)(OR5) darstellen
und
R4 und R5 unabhängig voneinander Wasserstoffatome, gegebenenfalls Hydroxy- oder Alkyloxy-substituierte unverzweigte, verzweigte oder cyclische Alkyl-, Alkenyl-, 1-Oxoalkyl oder 1-Oxoalkenylgruppen mit 1 bis 18 Kohlenstoffatomen,
gegebenenfalls substituierte Arylgruppen mit 6 bis 15 Kohlenstoff atomen,
gegebenenfalls substituierte Arylalkyl- oder Aryl-1-oxoalkylgruppen von 7 bis 16 Kohlenstoffatomen,
darstellen,
als Antioxidantien oder Radikalfänger.1. Use of the 2-hydrazino-1,3-thiazoles of the general formula
or their salts,
in which
X represents a nitrogen atom or a substituted carbon atom CQ 2 ,
and
either
Q 1 and Q 2 independently of one another are hydrogen atoms,
optionally hydroxyl- or alkyloxy-substituted unbranched, branched or cyclic alkyl, alkenyl, 1-oxoalkyl or 1-oxoalkenyl groups with 1 to 18 carbon atoms,
optionally substituted aryl groups with 6 to 15 carbon atoms,
optionally substituted heterocyclyl groups with 2 to 15 carbon atoms and at least one heteroatom selected from the group consisting of oxygen, nitrogen or sulfur,
optionally substituted arylalkyl or aryl-1-oxoalkyl groups of 7 to 16 carbon atoms,
Halogen atoms, nitro groups or
Represent groups -COOR 4 , -OR 4 , -NR 4 R 5 , -SO 2 OR 5 , -SO 2 NR 4 R 5 or -PO (OR 4 ) (OR 5 ),
or
Q 1 and Q 2 together represent a radical of the general formula (II)
represent
in which
X 1 , X 2 and X 3 independently of one another represent either nitrogen atoms or carbon atoms with the radicals R 1 , R 2 or R 3 ,
and
R 1 , R 2 and R 3 independently of one another are hydrogen atoms,
optionally hydroxyl- or alkyloxy-substituted unbranched, branched or cyclic alkyl, alkenyl, 1-oxoalkyl or 1-oxo alkenyl groups with 1 to 18 carbon atoms,
optionally substituted aryl groups with 6 to 15 carbon atoms,
optionally substituted heterocyclyl groups with 2 to 15 carbon atoms and at least one heteroatom selected from the group consisting of oxygen, nitrogen or sulfur,
optionally substituted arylalkyl or aryl-1-oxoalkyl groups of 7 to 16 carbon atoms,
Halogen atoms, nitro groups or
Represent groups -COOR 4 , -OR 4 , -NR 4 R 5 , -SO 2 OR 4 , -SO 2 NR 4 R 5 or -PO (OR 4 ) (OR 5 )
and
R 4 and R 5 independently of one another are hydrogen atoms, optionally hydroxyl- or alkyloxy-substituted unbranched, branched or cyclic alkyl, alkenyl, 1-oxoalkyl or 1-oxoalkenyl groups having 1 to 18 carbon atoms,
optionally substituted aryl groups with 6 to 15 carbon atoms,
optionally substituted arylalkyl or aryl-1-oxoalkyl groups of 7 to 16 carbon atoms,
represent
as antioxidants or radical scavengers.
oder deren Salze,
wobei
X ein Stickstoffatom oder ein mit Q2 substituiertes Kohlenstoffatom C- Q2 darstellt,
und
entweder
Q1 und Q2 unabhängig voneinander Wasserstoffatome, Methyl-, Trifluor methyl-, Ethyl-, tert.-Butyl-, Allyl-, 3-Methylbut-2-en-1-yl- oder Acetylgruppen, Chlor- oder Fluoratome, Nitrogruppen, Gruppen -COOR4, -OR4, -NR4R5, -SO2OR4, -SO2NR4R5, -PO(OR4)(OR5), oder am Aromaten gegebenenfalls mit Alkyl-, Hydroxy-, Alkyloxy-, Amino-, Dialkylamino-, Brom-, Fluor-, Chlor-, Nitril-, Sulfonsäure-, Sulfonamid- oder Alkylsulfonatresten substituierte Phenyl-, Pyridyl-, Pyrazinylgruppen, Phenylmethyl- oder Benzoylgruppen darstellen,
oder
Q1 und Q2 zusammen einen Rest der allgemeinen Formel (II)
darstellen,
wobei
X1, X2 und X3 Kohlenstoffatome mit den Resten R1, R2 bzw. R3 darstellen,
und
R1, R2 und R3 unabhängig voneinander Wasserstoffatome, Methyl-, Trifluor methyl-, Ethyl-, tert.-Butyl-, Allyl-, 3-Methylbut-2-en-1-yl- oder Acetylgruppen, Phenyl-, Pyridyl-, Pyrazinylgruppen, Phenylmethyl-, 4-Methylphenylmethyl-, 4-Methoxyphenylmethyl- oder Benzoyl gruppen, Chlor- oder Fluoratome, Nitrogruppen, Gruppen -COOR4, -OR4, NR4R5, -SO2OR4, -SO2NR4R5 oder -PO(OR4)(OR5) darstellen
und
R4 und R5 unabhängig voneinander Wasserstoffatome, Methyl-, Trifluor methyl-, Ethyl-, tert.-Butyl-, Allyl-, 3-Methylbut-2-en-1-yl-, Acetyl-, Propionyl oder Pivaloylgruppen, Phenyl-, Pyridyl-, Pyrazinylgruppen, Phenylmethyl-, 4-Methylphenylmethyl-, 4-Methoxyphenylmethyl- oder Benzoylgruppen darstellen
als Antioxidantien oder Radikalfänger.2. Use of the 2-hydrazino-1,3-thiazoles of the general formula (I)
or their salts,
in which
X represents a nitrogen atom or a substituted carbon atom Q 2 Q 2 C-,
and
either
Q 1 and Q 2 independently of one another are hydrogen atoms, methyl, trifluoromethyl, ethyl, tert-butyl, allyl, 3-methylbut-2-en-1-yl or acetyl groups, chlorine or fluorine atoms, nitro groups, Groups -COOR 4 , -OR 4 , -NR 4 R 5 , -SO 2 OR 4 , -SO 2 NR 4 R 5 , -PO (OR 4 ) (OR 5 ), or on the aromatic optionally with alkyl, hydroxy , Alkyloxy, amino, dialkylamino, bromine, fluorine, chlorine, nitrile, sulfonic acid, sulfonamide or alkylsulfonate radicals represent substituted phenyl, pyridyl, pyrazinyl, phenylmethyl or benzoyl groups,
or
Q 1 and Q 2 together represent a radical of the general formula (II)
represent
in which
X 1 , X 2 and X 3 represent carbon atoms with the radicals R 1 , R 2 and R 3 ,
and
R 1 , R 2 and R 3 independently of one another hydrogen atoms, methyl, trifluoromethyl, ethyl, tert-butyl, allyl, 3-methylbut-2-en-1-yl or acetyl groups, phenyl, pyridyl -, Pyrazinyl groups, phenylmethyl, 4-methylphenylmethyl, 4-methoxyphenylmethyl or benzoyl groups, chlorine or fluorine atoms, nitro groups, groups -COOR 4 , -OR 4 , NR 4 R 5 , -SO 2 OR 4 , -SO 2 Represent NR 4 R 5 or -PO (OR 4 ) (OR 5 )
and
R 4 and R 5 independently of one another are hydrogen atoms, methyl, trifluoromethyl, ethyl, tert-butyl, allyl, 3-methylbut-2-en-1-yl, acetyl, propionyl or pivaloyl groups, phenyl groups Represent pyridyl, pyrazinyl, phenylmethyl, 4-methylphenylmethyl, 4-methoxyphenylmethyl or benzoyl groups
as antioxidants or radical scavengers.
oder deren Salze,
wobei
X ein Stickstoffatom oder ein mit Q2 substituiertes Kohlenstoffatom C- Q2 darstellt,
und
entweder
Q1 und Q2 unabhängig voneinander Wasserstoffatome, Methyl-, Trifluor methyl-, Ethyl-, tert.-Butyl-, Allyl-, 3-Methylbut-2-en-1-yl- oder Acetylgruppen, Chlor- oder Fluoratome, Nitrogruppen, Gruppen -COOR4, -OR4, -NR4R5, -SO2OR4, -SO2NR4R5, -PO(OR4)(OR5), oder am Aromaten gegebenenfalls mit Alkyl-, Hydroxy-, Alkyloxy-, Amino-, Dialkylamino-, Brom-, Fluor-, Chlor-, Nitril-, Sulfonsäure-, Sulfonamid- oder Alkylsulfonatresten substituierte Phenyl-, Pyridyl-, Pyrazinylgruppen, Phenylmethyl- oder Benzoylgruppen darstellen,
oder
Q1 und Q2 zusammen einen Rest der allgemeinen Formel (II)
darstellen,
wobei
X1, X2 und X3 Kohlenstoffatome mit den Resten R1, R2 bzw. R3 darstellen,
und
R1, R2 und R3 unabhängig voneinander Wasserstoffatome, Methyl-, Trifluor methyl-, Ethyl-, tert.-Butyl-, Allyl-, 3-Methylbut-2-en-1-yl- oder Acetylgruppen, Phenyl-, Pyridyl-, Pyrazinylgruppen, Phenylmethyl-, 4-Methylphenylmethyl-, 4-Methoxyphenylmethyl- oder Benzoyl gruppen, Chlor- oder Fluoratome, Nitrogruppen, Gruppen -COOR4, -OR4, -NR4R5, -SO2OR4, -SO2NR4R5 oder -PO(OR4)(OR5) darstellen
und
R4 und R5 unabhängig voneinander Wasserstoffatome, Methyl-, Trifluor methyl-, Ethyl-, tert.-Butyl-, Allyl-, 3-Methylbut-2-en-1-yl-, Acetyl-, Propionyl oder Pivaloylgruppen, Phenyl-, Pyridyl-, Pyrazinylgruppen, Phenylmethyl-, 4-Methylphenylmethyl-, 4-Methoxyphenylmethyl- oder Benzoylgruppen darstellen. 4. Cosmetic, dermatological and nutritional or pleasure-making preparations containing the 2-hydrazino-1,3-thiazoles of the general formula (I)
or their salts,
in which
X represents a nitrogen atom or a substituted carbon atom Q 2 Q 2 C-,
and
either
Q 1 and Q 2 independently of one another are hydrogen atoms, methyl, trifluoromethyl, ethyl, tert-butyl, allyl, 3-methylbut-2-en-1-yl or acetyl groups, chlorine or fluorine atoms, nitro groups, Groups -COOR 4 , -OR 4 , -NR 4 R 5 , -SO 2 OR 4 , -SO 2 NR 4 R 5 , -PO (OR 4 ) (OR 5 ), or on the aromatic optionally with alkyl, hydroxy , Alkyloxy, amino, dialkylamino, bromine, fluorine, chlorine, nitrile, sulfonic acid, sulfonamide or alkylsulfonate radicals represent substituted phenyl, pyridyl, pyrazinyl, phenylmethyl or benzoyl groups,
or
Q 1 and Q 2 together represent a radical of the general formula (II)
represent
in which
X 1 , X 2 and X 3 represent carbon atoms with the radicals R 1 , R 2 and R 3 ,
and
R 1 , R 2 and R 3 independently of one another hydrogen atoms, methyl, trifluoromethyl, ethyl, tert-butyl, allyl, 3-methylbut-2-en-1-yl or acetyl groups, phenyl, pyridyl -, Pyrazinyl groups, phenylmethyl, 4-methylphenylmethyl, 4-methoxyphenylmethyl or benzoyl groups, chlorine or fluorine atoms, nitro groups, groups -COOR 4 , -OR 4 , -NR 4 R 5 , -SO 2 OR 4 , -SO 2 NR 4 R 5 or -PO (OR 4 ) (OR 5 )
and
R 4 and R 5 independently of one another are hydrogen atoms, methyl, trifluoromethyl, ethyl, tert-butyl, allyl, 3-methylbut-2-en-1-yl, acetyl, propionyl or pivaloyl groups, phenyl groups Represent pyridyl, pyrazinyl, phenylmethyl, 4-methylphenylmethyl, 4-methoxyphenylmethyl or benzoyl groups.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10052590A DE10052590A1 (en) | 2000-10-24 | 2000-10-24 | Use of 2-hydrazino-1,3-thiazoles as antioxidants |
PCT/EP2001/011757 WO2002034265A1 (en) | 2000-10-24 | 2001-10-11 | Use of 2-hydrazino-1,3-thiazoles as antioxidants |
AU2002223611A AU2002223611A1 (en) | 2000-10-24 | 2001-10-11 | Use of 2-hydrazino-1,3-thiazoles as antioxidants |
US10/001,589 US20020128268A1 (en) | 2000-10-24 | 2001-10-19 | Use of 2-hydrazino-1,3-thiazoles as antioxidants |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10052590A DE10052590A1 (en) | 2000-10-24 | 2000-10-24 | Use of 2-hydrazino-1,3-thiazoles as antioxidants |
Publications (1)
Publication Number | Publication Date |
---|---|
DE10052590A1 true DE10052590A1 (en) | 2002-05-02 |
Family
ID=7660816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE10052590A Withdrawn DE10052590A1 (en) | 2000-10-24 | 2000-10-24 | Use of 2-hydrazino-1,3-thiazoles as antioxidants |
Country Status (4)
Country | Link |
---|---|
US (1) | US20020128268A1 (en) |
AU (1) | AU2002223611A1 (en) |
DE (1) | DE10052590A1 (en) |
WO (1) | WO2002034265A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2724709A1 (en) * | 2012-10-24 | 2014-04-30 | Unilever N.V. | A sunscreen composition containing ester salts of L-DOPA |
US9408796B2 (en) | 2013-03-13 | 2016-08-09 | Avon Products, Inc | Cosmetic compositions for improving the appearance of skin |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1578135A (en) * | 1976-06-17 | 1980-11-05 | Reckitt & Colmann Prod Ltd | Compositions containing thiadiazole derivatives |
DE3413875A1 (en) * | 1984-04-12 | 1985-10-17 | Ludwig Heumann & Co GmbH, 8500 Nürnberg | BENZOTHIAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCT CONTAINING THESE COMPOUNDS |
PT638075E (en) * | 1993-02-26 | 2002-06-28 | Otsuka Pharma Co Ltd | INHIBITOR OF MAILLARD'S REACTION |
DE10008907A1 (en) * | 2000-02-25 | 2001-08-30 | Haarmann & Reimer Gmbh | Topical cosmetic compositions containing benzocondensed or heterocyclically condensed 2-hydrazino-1,3-heteroazoles |
-
2000
- 2000-10-24 DE DE10052590A patent/DE10052590A1/en not_active Withdrawn
-
2001
- 2001-10-11 WO PCT/EP2001/011757 patent/WO2002034265A1/en active Application Filing
- 2001-10-11 AU AU2002223611A patent/AU2002223611A1/en not_active Abandoned
- 2001-10-19 US US10/001,589 patent/US20020128268A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20020128268A1 (en) | 2002-09-12 |
WO2002034265A1 (en) | 2002-05-02 |
AU2002223611A1 (en) | 2002-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE19933460A1 (en) | Cosmetic or dermatological dispersions having radical scavenging and antioxidant activity, useful e.g. for preventing skin aging and inflammatory reactions | |
WO2008025755A1 (en) | Use of n-containing heterocycles in dermocosmetics | |
KR102090796B1 (en) | Sun-screen Composition Comprising Lignin | |
DE10030891A1 (en) | New 3,4-dihydroxybenzyl-substituted carbonic acid derivatives are antioxidants and radical scavengers useful e.g. for preventing skin aging or protecting cosmetic, dermatological or foodstuff compositions against oxidation | |
WO2001062208A2 (en) | Topical cosmetic agents containing 2-hydrazino-1,3-heteroazoles | |
JP2008239545A (en) | Elastase deactivator | |
WO2004022015A1 (en) | Use of diketopiperazine derivatives as photostable uv-filters in cosmetic and pharmaceutical preparations | |
EP1060734B1 (en) | Use of cyclic enamines as sun protection agents | |
EP1677742B1 (en) | Powdery preparations containing diethylamino-hydroxybenzoyl-hexyl-benzoate | |
JP5530058B2 (en) | Aqueous preparation with stabilized carotenoids | |
DE102006034320A1 (en) | Antioxidant, useful for preparation of e.g. coloring agent, vesicle, dermocosmetic, pharmaceuticals and nutrient- or feedstuff, comprises at least an isorenieratene compound | |
DE10140443A1 (en) | 2- (3,4-Dihydroxyphenyl) ethyl substituted carbonic acid derivatives and their use | |
DE10052590A1 (en) | Use of 2-hydrazino-1,3-thiazoles as antioxidants | |
WO2005025521A2 (en) | Powdered preparations containing a mixture of 2,4,6-trianilino-p-(carbo-2'-ethylhexyl-1'-oxi)-1,3,5-triazine and diethylamino-hydroxybenzoyl-hexyl-benzoate | |
DE19960105A1 (en) | Catechol oximes and their use in cosmetic and dermatological preparations | |
KR102183695B1 (en) | Composition for Preventing Discoloration | |
DE10030880A1 (en) | 3,4-Dihydroxymandelic acid alkylamides and their use | |
DE102006051088A1 (en) | Antioxidant, useful in the preparation of a dyeing agent, vesicle, carotenoid formulation, dermocosmetic, pharmaceutical, food, feed, gelatin capsule and/or solid- or liquid material, comprises an isorenieratene compound | |
DE10111728A1 (en) | UV filter | |
EP3517097A1 (en) | Fatty acid ethyl ester for cosmetic product | |
DE10328547A1 (en) | Mixture consisting of a UV-A and a UV-B filter | |
EP3570812B1 (en) | Cosmetic preparations containing sphereic silicone materials coated with titanium dioxide and iron oxides and medium-chained aliphatic dioles | |
EP1657294A1 (en) | Anti-allergenic perfume compositions | |
DE10013578A1 (en) | Use of 3,4-dihydroxymandelic acid and/or stereoisomers as antioxidants and/or radical scavengers in protecting mammalian skin, cosmetic or pharmaceutical preparations, foodstuffs, lacquers and polymers | |
EP0924246A1 (en) | Uses of Isoindolinone derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8127 | New person/name/address of the applicant |
Owner name: DRAGOCO GERBERDING & CO. AG, 37603 HOLZMINDEN, DE |
|
8127 | New person/name/address of the applicant |
Owner name: SYMRISE GMBH & CO. KG, 37603 HOLZMINDEN, DE |
|
8139 | Disposal/non-payment of the annual fee |